Target (48)
Compound (324)
Article Title (182)
Article Author (17)
Assay (402)
Fillion, D; Lemieux, G; Basambombo, LL; Lavigne, P; Guillemette, G; Leduc, R; Escher, E The amino-terminus of angiotensin II contacts several ectodomains of the angiotensin II receptor AT1. J Med Chem 53: 2063 -75 (2010) Juillerat-Jeanneret, L The Other Angiotensin II Receptor: AT J Med Chem 63: 1978 -1995 (2020) Bovy, PR; Reitz, DB; Collins, JT; Chamberlain, TS; Olins, GM; Corpus, VM; McMahon, EG; Palomo, MA; Koepke, JP; Smits, GJ Nonpeptide angiotensin II antagonists: N-phenyl-1H-pyrrole derivatives are angiotensin II receptor antagonists. J Med Chem 36: 101 -10 (1993) Atwal, KS; Ahmed, SZ; Bird, JE; Delaney, CL; Dickinson, KE; Ferrara, FN; Hedberg, A; Miller, AV; Moreland, S; O'Reilly, BC Dihydropyrimidine angiotensin II receptor antagonists. J Med Chem 35: 4751 -63 (1993) Inada, Y; Nakane, T; Chiba, S Binding of KRH-594, an antagonist of the angiotensin II type 1 receptor, to cloned human and rat angiotensin II receptors. Fundam Clin Pharmacol 16: 317 -23 (2002) Quan, ML; DeLucca, I; Boswell, GA; Chiu, AT; Wong, PC; Wexler, RR; Timmermans, PB Imidazolinones as nonpeptide angiotensin II receptor antagonists Bioorg Med Chem Lett 4: 1527 -1530 (1994) Dorsch, D; Mederski, WW; Osswald, M; Beier, N; Schelling, P Uracil-based angiotensin II receptor antagonists Bioorg Med Chem Lett 5: 2071 -2076 (1995) Levin, JI; Venkatesan, AM; Chan, PS; Baker, JS; Francisco, G; Bailey, T; Vice, G; Katocs, A; Lai, F; Coupet, J 2,3,6-Substituted quinazolinones as angiotensin II receptor antagonists Bioorg Med Chem Lett 4: 1135 -1140 (1994) Levin, JI; Venkatesan, AM; Chan, PS; Bailey, TK; Vice, G; Coupet, J 6-Substituted Quinazolinone Angiotensin II Receptor Antagonists Bioorg Med Chem Lett 4: 1819 -1824 (1994) Gopalan, G; Palo-Nieto, C; Petersen, NN; Hallberg, M; Larhed, M Angiotensin II AT2 receptor ligands with phenylthiazole scaffolds. Bioorg Med Chem 65: (2022) Mantlo, N; Chang, RS; Siegl, P Angiotensin II receptor antagonists containing a phenylpyridine element. Bioorg Med Chem Lett 3: 1693 -1696 (1993) Kritsi, E; Matsoukas, MT; Potamitis, C; Karageorgos, V; Detsi, A; Magafa, V; Liapakis, G; Mavromoustakos, T; Zoumpoulakis, P Exploring new scaffolds for angiotensin II receptor antagonism. Bioorg Med Chem 24: 4444 -4451 (2016) Ellingboe, JW; Antane, M; Nguyen, TT; Collini, MD; Antane, S; Bender, R; Hartupee, D; White, V; McCallum, J; Park, CH Pyrido[2,3-d]pyrimidine angiotensin II antagonists. J Med Chem 37: 542 -50 (1994) Murray, W; Lalan, P; Gill, A; Lee, D; Falotico, R; Lewis, J; Addo, M; Wachter, M Substituted lactam biphenyltetrazoles as angiotensin II mediated antihypertensives Bioorg Med Chem Lett 4: 87 -92 (1994) Olson, RE; Liu, J; Lalka, GK; VanAtten, MK; Wexler, RR; Chiu, AT; Nguyen, TT; McCall, DE; Wong, PC; Timmermans, PB Balanced angiotensin II receptor antagonists. II.1,2 4-aminomethyl- and acylaminomethylimidazoles Bioorg Med Chem Lett 4: 2229 -2234 (1994) Norman, MH; Smith, HD; Andrews, CW; Tang, FL; Cowan, CL; Steffen, RP 4-(Heteroarylthio)-2-biphenylyltetrazoles as nonpeptide angiotensin II antagonists. J Med Chem 38: 4670 -8 (1995) Cho, N; Kubo, K; Furuya, S; Sugiura, Y; Yasuma, T; Kohara, Y; Ojima, M; Inada, Y; Nishikawa, K; Naka, T A new class of diacidic nonpeptide angiotensin II receptor antagonists Bioorg Med Chem Lett 4: 35 -40 (1994) Lloyd, J; Ryono, DE; Bird, JE; Buote, J; Delaney, CL; Dejneka, T; Dickinson, KE; Moreland, S; Normandin, DE; Skwish, S; Spitzmiller, ER; Waldron, TL Quinoline-4-carboxylic acids as angiotensin II receptor antagonists Bioorg Med Chem Lett 4: 195 -200 (1994) Murray, WV; Lalan, P; Gill, A; Addo, MF; Lewis, JM; Lee, DK; Rampulla, R; Wachter, MP; Hsi, JD; Underwood, DC Substituted piperidin-2-one biphenyltetrazoles as angiotensin II antagonists Bioorg Med Chem Lett 2: 1775 -1779 (1992) Murray, WV; Lalan, P; Gill, A; Addo, MF; Lewis, JM; Lee, DK; Wachter, MP; Rampulla, R; Underwood, DC Substituted pyrrolidin-2-one biphenyltetrazoles as angiotensin II antagonists Bioorg Med Chem Lett 3: 369 -374 (1993) Winn, M; De, B; Zydowsky, TM; Altenbach, RJ; Basha, FZ; Boyd, SA; Brune, ME; Buckner, SA; Crowell, D; Drizin, I 2-(Alkylamino)nicotinic acid and analogs. Potent angiotensin II antagonists. J Med Chem 36: 2676 -88 (1993) Levin, JI; Chan, PS; Coupet, J; Bailey, TK; Vice, G; Thibault, L; F., L; Venkatesan, AM; Cobuzzi, A 6-isoxazolinyl and isoxazolidinyl substituted quinazolinones as angiotensin II receptor antagonists Bioorg Med Chem Lett 4: 1703 -1708 (1994) Kohara, Y; Imamiya, E; Kubo, K; Wada, T; Inada, Y; Naka, T A new class of angiotensin II receptor antagonists with a novel acidic bioisostere Bioorg Med Chem Lett 5: 1903 -1908 (1995) Schmidt, B; Schieffer, B Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites. J Med Chem 46: 2261 -70 (2003) Spear, KL; Brown, MS; Reinhard, EJ; McMahon, EG; Olins, GM; Palomo, MA; Patton, DR Conformational restriction of angiotensin II: cyclic analogues having high potency. J Med Chem 33: 1935 -40 (1990) Miyake, K; Matsukura, M; Yoneda, N; Hiroshima, O; Mori, N; Ishihara, H; Musha, T; Matsuoka, T; Shoji, T; Minami, N; Hamano, S; Saito, I Discovery and development of aryl-fused imidazole-based angiotensin II antagonists Bioorg Med Chem Lett 4: 213 -218 (1994) Huang, HC; Chamberlain, TS; Olins, GM; Corpus, VM; Chen, ST; McMahon, EG; Palomo, MA; Blaine, EH; Manning, RE Discovery of nonpeptide potent conformationally restricted angiotensin II receptor antagonists Bioorg Med Chem Lett 4: 2591 -2596 (1994) Glinka, TW; de Laszlo, SE; Tran, J; Chang, RS; Chen, T; Lotti, VJ; Greenlee, WJ L-161,638: A potent AT2selective quinazolinone angiotensin II binding inhibitor Bioorg Med Chem Lett 4: 1479 -1484 (1994) Ellingboe, JW; Collini, MD; Quagliato, D; Chen, J; Antane, M; Schmid, J; Hartupee, D; White, V; Park, CH; Tanikella, T; Bagli, JF Metabolites of the angiotensin II antagonist tasosartan: the importance of a second acidic group. J Med Chem 41: 4251 -60 (1998) Wexler, RR; Greenlee, WJ; Irvin, JD; Goldberg, MR; Prendergast, K; Smith, RD; Timmermans, PB Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy. J Med Chem 39: 625 -56 (1996) Elokdah, HM; Friedrichs, GS; Chai, SY; Harrison, BL; Primeau, J; Chlenov, M; Crandall, DL Novel human metabolites of the angiotensin-II antagonist tasosartan and their pharmacological effects. Bioorg Med Chem Lett 12: 1967 -71 (2002) Kushida, H; Nomura, S; Morita, O; Harasawa, Y; Suzuki, M; Nakano, M; Ozawa, K; Kunihara, M Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, U-97018. J Pharmacol Exp Ther 274: 1042 -53 (1995) Sallander, J; Wallinder, C; Hallberg, A; Åqvist, J; Gutiérrez-de-Terán, H Structural determinants of subtype selectivity and functional activity of angiotensin II receptors. Bioorg Med Chem Lett 26: 1355 -9 (2016) Veron, JB; Joshi, A; Wallinder, C; Larhed, M; Odell, LR Synthesis and evaluation of isoleucine derived angiotensin II AT(2) receptor ligands. Bioorg Med Chem Lett 24: 476 -9 (2014) Dorsch, D; Mederski, WW; Beier, N; Lues, I; Minck, K; Schelling, P (6-oxo-3-pyridazinyl)-benzimidazoles as potent angiotensin II receptor antagonists Bioorg Med Chem Lett 4: 1297 -1302 (1994) Dhanoa, DS; Bagley, SW; Chang, RS; Lotti, VJ; Chen, TB; Kivlighn, SD; Zingaro, GJ; Siegl, PK; Chakravarty, PK; Patchett, AA (Dipropylphenoxy)phenylacetic acids: a new generation of nonpeptide angiotensin II receptor antagonists. J Med Chem 36: 3738 -42 (1994) Kim, D; Mantlo, NB; Tata, JR; Fitch, K; Dhanoa, D; Owens, K; Levorse, D; Siegl, PK; Chang, RS; Chen, T; Scheck, S; Zingaro, GJ; Kivlighn, SD; Greenlee, WJ Acidic phenols: a new class of potent nonpeptide angiotensin II receptor antagonists Bioorg Med Chem Lett 4: 207 -212 (1994) Johannesson, P; Lindeberg, G; Tong, W; Gogoll, A; Synnergren, B; Nyberg, F; Karlén, A; Hallberg, A Angiotensin II analogues encompassing 5,9- and 5,10-fused thiazabicycloalkane tripeptide mimetics. J Med Chem 42: 4524 -37 (1999) Yanagisawa, H; Amemiya, Y; Kanazaki, T; Fujimoto, K; Shimoji, Y; Fujimoto, Y; Sada, T; Mizuno, M; Koike, H Angiotensin II receptor antagonists: imidazoles and pyrroles bearing hydroxymethyl and carboxy substituents Bioorg Med Chem Lett 4: 177 -182 (1994) Naik, P; Murumkar, P; Giridhar, R; Yadav, MR Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists--a perspective. Bioorg Med Chem 18: 8418 -56 (2010) Bovy, PR; Collins, JT; Olins, GM; McMahon, EG; Hutton, WC Conformationally restricted polysubstituted biphenyl derivatives with angiotensin II receptors antagonist properties. J Med Chem 34: 2410 -4 (1991) Perreaut, P; Clément, J; Muneaux, C; Muneaux, Y; Cazaubon, C; Gougat, J; Guiraudou, P; Lacour, C; Nisato, D; Fur, GL; Breliere, JC Dihydro-imidazolone derivatives as angiotensin II receptor antagonists: chiral effect on the activity Bioorg Med Chem Lett 4: 163 -168 (1994) De, B; Winn, M; Zydowsky, TM; Kerkman, DJ; DeBernardis, JF; Lee, J; Buckner, S; Warner, R; Brune, M; Hancock, A Discovery of a novel class of orally active, non-peptide angiotensin II antagonists. J Med Chem 35: 3714 -7 (1992) Ohno, O; Ye, M; Koyama, T; Yazawa, K; Mura, E; Matsumoto, H; Ichino, T; Yamada, K; Nakamura, K; Ohno, T; Yamaguchi, K; Ishida, J; Fukamizu, A; Uemura, D Inhibitory effects of benzyl benzoate and its derivatives on angiotensin II-induced hypertension. Bioorg Med Chem 16: 7843 -52 (2008) Kubo, K; Kohara, Y; Imamiya, E; Sugiura, Y; Inada, Y; Furukawa, Y; Nishikawa, K; Naka, T Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazolecarboxylic acids. J Med Chem 36: 2182 -95 (1993) Chakravarty, PK; Strelitz, RA; Chen, TB; Chang, RS; Lotti, VJ; Zingaro, GJ; Schorn, TW; Kivlighn, SD; Siegel, PK; Patchett, AA; Greenlee, WJ Quinazolinone Biphenyl Acylsulfonamides: A potent new class of angiotensin-II receptor antagonists Bioorg Med Chem Lett 4: 75 -80 (1994) Murugaiah, AM; Wallinder, C; Mahalingam, AK; Wu, X; Wan, Y; Plouffe, B; Botros, M; Karlén, A; Hallberg, M; Gallo-Payet, N; Alterman, M Selective angiotensin II AT(2) receptor agonists devoid of the imidazole ring system. Bioorg Med Chem 15: 7166 -83 (2007) Mahalingam, AK; Wan, Y; Murugaiah, AM; Wallinder, C; Wu, X; Plouffe, B; Botros, M; Nyberg, F; Hallberg, A; Gallo-Payet, N; Alterman, M Selective angiotensin II AT(2) receptor agonists with reduced CYP 450 inhibition. Bioorg Med Chem 18: 4570 -90 (2010) Wallinder, C; Botros, M; Rosenström, U; Guimond, MO; Beaudry, H; Nyberg, F; Gallo-Payet, N; Hallberg, A; Alterman, M Selective angiotensin II AT2 receptor agonists: Benzamide structure-activity relationships. Bioorg Med Chem 16: 6841 -9 (2008) Wu, X; Wan, Y; Mahalingam, AK; Murugaiah, AM; Plouffe, B; Botros, M; Karlén, A; Hallberg, M; Gallo-Payet, N; Alterman, M Selective angiotensin II AT2 receptor agonists: arylbenzylimidazole structure-activity relationships. J Med Chem 49: 7160 -8 (2006) Nouet, S; Dodey, PR; Bondoux, MR; Pruneau, D; Luccarini, JM; Groblewski, T; Larguier, R; Lombard, C; Marie, J; Renaut, PP; Leclerc, G; Bonnafous, JC Specific nonpeptide photoprobes as tools for the structural study of the angiotensin II AT(1) receptor. J Med Chem 42: 4572 -83 (1999) Zydowsky, TM; Winn, M; De, B; Condon, SL; Altenbach, RJ; Basha, FZ; Boyd, SA; Buckner, SA; Hancock, AA; Lee, JY; Mantei, RA; Novosad, EI; Sorensen, BK; Tasker, AS; Shiosaki, K; Kerkman, DJ; Opgenorth, TJ; DeBernardis, JF Synthesis and In Vitro evaluation of fused ring heterocyle-containing angiotensin II antagonists. Bioorg Med Chem Lett 4: 173 -176 (1994) Sircar, I; Winters, RT; Quin, J; Lu, GH; Major, TC; Panek, RL Nonpeptide angiotensin II receptor antagonists. 1. Synthesis and in vitro structure-activity relationships of 4-[[[(1H-pyrrol-1-ylacetyl)amino]phenyl]methyl]imidazole derivatives as angiotensin II receptor antagonists. J Med Chem 36: 1735 -45 (1993) VanAtten, MK; Ensinger, CL; Chiu, AT; McCall, DE; Nguyen, TT; Wexler, RR; Timmermans, PB A novel series of selective, non-peptide inhibitors of angiotensin II binding to the AT2 site. J Med Chem 36: 3985 -92 (1994) Hirata, T; Nomiyama, J; Sakae, N; Nishimura, K; Yokomoto, M; Inoue, S; Tamura, K; Okuhira, M; Amano, H; Nagao, Y Acyliminothiadiazoline derivatives: New, highly potent, and orally active angiotensin II receptor antagonists Bioorg Med Chem Lett 6: 1469 -1474 (1996) Santella, JB; Duncia, JV; Ensinger, CL; VanAtten, MK; Carini, DJ; Wexler, RR; Chiu, AT; Wong, PC; Timmermans, PB Balanced angiotensin II receptor antagonists. III. The effects of substitution at the imidazole 5-position. Bioorg Med Chem Lett 4: 2235 -2240 (1994) Bernhart, CA; Hundricourt, FB; Assens, JL; Gougat, J; Lacour, C; Roccon, A; Cazaubon, C; Brelière, JC; Fur, GL; Nisato, D Cyclopentanespiro-3H-dihydro-pyrimidinones as Angiotensin II AT1 receptor antagonists Bioorg Med Chem Lett 4: 157 -162 (1994) Murugesan, N; Tellew, JE; Gu, Z; Kunst, BL; Fadnis, L; Cornelius, LA; Baska, RA; Yang, Y; Beyer, SM; Monshizadegan, H; Dickinson, KE; Panchal, B; Valentine, MT; Chong, S; Morrison, RA; Carlson, KE; Powell, JR; Moreland, S; Barrish, JC; Kowala, MC; Macor, JE Discovery of N-isoxazolyl biphenylsulfonamides as potent dual angiotensin II and endothelin A receptor antagonists. J Med Chem 45: 3829 -35 (2002) Lamotte, Y; Faucher, N; Sançon, J; Pineau, O; Sautet, S; Fouchet, MH; Beneton, V; Tousaint, JJ; Saintillan, Y; Ancellin, N; Nicodeme, E; Grillot, D; Martres, P Discovery of novel indazole derivatives as dual angiotensin II antagonists and partial PPAR¿ agonists. Bioorg Med Chem Lett 24: 1098 -103 (2014) Krovat, EM; Langer, T Non-peptide angiotensin II receptor antagonists: chemical feature based pharmacophore identification. J Med Chem 46: 716 -26 (2003) Ryono, DE; Lloyd, J; Poss, MA; Bird, JE; Buote, J; Chong, S; Dejneka, T; Dickinson, KE; Gu, Z; Mathers, P; Moreland, S; Morrison, RA; Petrillo, EW; Powell, JR; Schaeffer, T; Spitzmiller, ER; White, RE Orally active prodrugs of quinoline-4-carboxylic acid angiotensin II receptor antagonists Bioorg Med Chem Lett 4: 201 -206 (1994) Venkatesan, AM; Levin, JI; Baker, JS; Chan, PS; Bailey, T; Coupet, J Substituted 4H-pyrido[1,2-a]pyrimidin-4-one angiotensin II receptor antagonists. Bioorg Med Chem Lett 4: 183 -188 (1994) Bao, X; Zhu, W; Zhang, R; Wen, C; Wang, L; Yan, Y; Tang, H; Chen, Z Synthesis and evaluation of novel angiotensin II receptor 1 antagonists as anti-hypertension drugs. Bioorg Med Chem 24: 2023 -31 (2016) Duncia, JV; Chiu, AT; Carini, DJ; Gregory, GB; Johnson, AL; Price, WA; Wells, GJ; Wong, PC; Calabrese, JC; Timmermans, PB The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensives. J Med Chem 33: 1312 -29 (1990) Thomas, AP; Roberts, DA; Thomason, DA The synthesis and biological activity of tetrahydroquinoline angiotensin II antagonists containing a substituted biphenyltetrazole group Bioorg Med Chem Lett 4: 2615 -2620 (1994) Weinstock, J; Keenan, RM; Samanen, J; Hempel, J; Finkelstein, JA; Franz, RG; Gaitanopoulos, DE; Girard, GR; Gleason, JG; Hill, DT 1-(carboxybenzyl)imidazole-5-acrylic acids: potent and selective angiotensin II receptor antagonists. J Med Chem 34: 1514 -7 (1991) Harmat, NJ; Giorgi, R; Bonaccorsi, F; Cerbai, G; Colombani, SM; Renzetti, AR; Cirillo, R; Subissi, A; Alagona, G; Ghio, C 4-Diazinyl- and 4-pyridinylimidazoles: potent angiotensin II antagonists. A study of their activity and computational characterization. J Med Chem 38: 2925 -37 (1995) Bernhart, CA; Perreaut, PM; Ferrari, BP; Muneaux, YA; Assens, JL; Clément, J; Haudricourt, F; Muneaux, CF; Taillades, JE; Vignal, MA A new series of imidazolones: highly specific and potent nonpeptide AT1 angiotensin II receptor antagonists. J Med Chem 36: 3371 -80 (1993) Weinstock, J; Hill, DT; Keenan, RM; Franz, RG; Gaitanopoulos, DE; Girard, GR; Eggleston, DS; Aiyar, N; Griffin, E; Ohlstein, E; Brooks, DP; Gellai, M; Frederickson, TA; Weidley, EF; Edwards, RM A potent long-acting imidazole-5-acrylic acid angiotensin II AT-1 receptor antagonist Bioorg Med Chem Lett 4: 23 -28 (1994) de Laszlo, SE; Quagliato, CS; Greenlee, WJ; Patchett, AA; Chang, RS; Lotti, VJ; Chen, TB; Scheck, SA; Faust, KA; Kivlighn, SS A potent, orally active, balanced affinity angiotensin II AT1 antagonist and AT2 binding inhibitor. J Med Chem 36: 3207 -10 (1993) Georgsson, J; Sköld, C; Plouffe, B; Lindeberg, G; Botros, M; Larhed, M; Nyberg, F; Gallo-Payet, N; Gogoll, A; Karlén, A; Hallberg, A Angiotensin II pseudopeptides containing 1,3,5-trisubstituted benzene scaffolds with high AT2 receptor affinity. J Med Chem 48: 6620 -31 (2005) Enyeart, JA; Liu, H; Enyeart, JJ Curcumin inhibits ACTH- and angiotensin II-stimulated cortisol secretion and Ca(v)3.2 current. J Nat Prod 72: 1533 -7 (2009) Zhang, J; Wang, JL; Yu, WF; Zhou, ZM; Tao, WC; Wang, YC; Xue, WZ; Xu, D; Hao, LP; Han, XF; Fei, F; Liu, T; Liang, AH Nonpeptidic angiotensin II AT? receptor antagonists derived from 6-substituted aminocarbonyl and acylamino benzimidazoles. Eur J Med Chem 69: 44 -54 (2013) Bühlmayer, P; Criscione, L; Fuhrer, W; Furet, P; de Gasparo, M; Stutz, S; Whitebread, S Nonpeptidic angiotensin II antagonists: synthesis and in vitro activity of a series of novel naphthalene and tetrahydronaphthalene derivatives. J Med Chem 34: 3105 -14 (1991) Mantlo, NB; Chakravarty, PK; Ondeyka, DL; Siegl, PK; Chang, RS; Lotti, VJ; Faust, KA; Chen, TB; Schorn, TW; Sweet, CS Potent, orally active imidazo[4,5-b]pyridine-based angiotensin II receptor antagonists. J Med Chem 34: 2919 -22 (1991) Levin, JI; Chan, PS; Coupet, J; Thibault, L; Venkatesan, AM; Bailey, TK; Vice, G; Cobuzzi, A; Lai, F; Mellish, N Synthesis and biological evaluation of the potent isoxazolidinyl angiotensin II receptor antagonist CL332,877 and its enantiomers. Bioorg Med Chem Lett 4: 1709 -1714 (1994) Huang, HC; Reitz, DB; Chamberlain, TS; Olins, GM; Corpus, VM; McMahon, EG; Palomo, MA; Koepke, JP; Smits, GJ; McGraw, DE Synthesis and structure-activity relationships of nonpeptide, potent triazolone-based angiotensin II receptor antagonists. J Med Chem 36: 2172 -81 (1993) Georgsson, J; Sköld, C; Botros, M; Lindeberg, G; Nyberg, F; Karlén, A; Hallberg, A; Larhed, M Synthesis of a new class of druglike angiotensin II C-terminal mimics with affinity for the AT2 receptor. J Med Chem 50: 1711 -5 (2007) Klutchko, S; Hamby, JM; Hodges, JC Tetrahydroisoquinoline derivatives with AT2 -specific angiotensin II reception binding inhibitory activity Bioorg Med Chem Lett 4: 57 -62 (1994) Chang, LL; Ashton, WT; Flanagan, KL; Chen, TB; O'Malley, SS; Zingaro, GJ; Siegl, PK; Kivlighn, SD; Lotti, VJ; Chang, RS Triazolinone biphenylsulfonamides as angiotensin II receptor antagonists with high affinity for both the AT1 and AT2 subtypes. J Med Chem 37: 4464 -78 (1995) Chang, LL; Ashton, WT; Flanagan, KL; Strelitz, RA; MacCoss, M; Greenlee, WJ; Chang, RS; Lotti, VJ; Faust, KA; Chen, TB Triazolinones as nonpeptide angiotensin II antagonists. 1. Synthesis and evaluation of potent 2,4,5-trisubstituted triazolinones. J Med Chem 36: 2558 -68 (1993) Chang, LL; Ashton, WT; Flanagan, KL; Naylor, EM; Chakravarty, PK; Patchett, AA; Greenlee, WJ; Bendesky, RJ; Chen, TB; Faust, KA; Kling, PJ; Schaffer, LW; Schorn, TW; Zingaro, GJ; Chang, RS; Lotti, VJ; Kivlighn, SD; Siegl, PK Triazolinones as nonpeptide angiotensin II antagonists. 2. discovery of a potent and orally active triazolinone acylsulfonamide Bioorg Med Chem Lett 4: 115 -120 (1994) Deprez, P; Guillaume, J; Corbier, A; Fortin, M; Vevert, JP; Heckmann, B Balanced AT1 and AT2 angiotensin II antagonists. II. Potent 5 α-hydroxyacid imidazolyl biphenyl sulfonylureas Bioorg Med Chem Lett 5: 2611 -2616 (1995) Hsieh, KH; LaHann, TR; Speth, RC Topographic probes of angiotensin and receptor: potent angiotensin II agonist containing diphenylalanine and long-acting antagonists containing biphenylalanine and 2-indan amino acid in position 8. J Med Chem 32: 898 -903 (1989) Johannesson, P; Erdélyi, M; Lindeberg, G; Frändberg, PA; Nyberg, F; Karlén, A; Hallberg, A AT2-selective angiotensin II analogues containing tyrosine-functionalized 5,5-bicyclic thiazabicycloalkane dipeptide mimetics. J Med Chem 47: 6009 -19 (2004) Fitch, KJ; Walsh, TF; Patchett, AA; Chang, RS; Siegl, PK; Faust, KA; Chen, TB; Lotti, VJ; Kivlighn, SD; Zingaro, GJ; Greenlee, WJ AT1 selective angiotensin II antagonists with phenoxyphenylacetic acid as a biphenyl replacement part I Bioorg Med Chem Lett 5: 155 -158 (1995) Kim, D; Mantlo, NB; Chang, RS; Kivlighn, SD; Greenlee, WJ Evaluation of heterocyclic acid equivalents as tetrazole replacements in imidazopyridine-based nonpeptide angiotensin II receptor antagonists Bioorg Med Chem Lett 4: 41 -44 (1994) Salimbeni, A; Canevotti, R; Paleari, F; Poma, D; Caliari, S; Fici, F; Cirillo, R; Renzetti, AR; Subissi, A; Belvisi, L N-3-substituted pyrimidinones as potent, orally active, AT1 selective angiotensin II receptor antagonists. J Med Chem 38: 4806 -20 (1996) Carini, DJ; Duncia, JV; Johnson, AL; Chiu, AT; Price, WA; Wong, PC; Timmermans, PB Nonpeptide angiotensin II receptor antagonists: N-[(benzyloxy)benzyl]imidazoles and related compounds as potent antihypertensives. J Med Chem 33: 1330 -6 (1990) Zhang, WJ; Nikiforovich, GV; Pérodin, J; Richard, DE; Escher, E; Marshall, GR Novel cyclic analogs of angiotensin II with cyclization between positions 5 and 7: conformational and biological implications. J Med Chem 39: 2738 -44 (1996) Chang, LL; Ashton, WT; Flanagan, KL; Chen, TB; O'Malley, SS; Zingaro, GJ; Kivlighn, SD; Siegl, PK; Lotti, VJ; Chang, RS Potent and orally active angiotensin II receptor antagonists with equal affinity for human AT1 and AT2 subtypes. J Med Chem 38: 3741 -58 (1995) Keenan, RM; Weinstock, J; Finkelstein, JA; Franz, RG; Gaitanopoulos, DE; Girard, GR; Hill, DT; Morgan, TM; Samanen, JM; Peishoff, CE Potent nonpeptide angiotensin II receptor antagonists. 2. 1-(Carboxybenzyl)imidazole-5-acrylic acids. J Med Chem 36: 1880 -92 (1993) Nicolaï, E; Curé, G; Goyard, J; Kirchner, M; Teulon, JM; Versigny, A; Cazes, M; Caussade, F; Virone-Oddos, A; Cloarec, A Synthesis and SAR studies of novel triazolopyrimidine derivatives as potent, orally active angiotensin II receptor antagonists. J Med Chem 37: 2371 -86 (1994) Le Bourdonnec, B; Meulon, E; Yous, S; Goossens, JF; Houssin, R; Hénichart, JP Synthesis and pharmacological evaluation of new pyrazolidine-3, 5-diones as AT(1) angiotensin II receptor antagonists. J Med Chem 43: 2685 -97 (2000) Johannesson, P; Lindeberg, G; Johansson, A; Nikiforovich, GV; Gogoll, A; Synnergren, B; Le Grèves, M; Nyberg, F; Karlén, A; Hallberg, A Vinyl sulfide cyclized analogues of angiotensin II with high affinity and full agonist activity at the AT(1) receptor. J Med Chem 45: 1767 -77 (2002) Walsh, TF; Fitch, KJ; Chang, RS; Faust, KA; Chen, TB; Kivlighn, SD; Zingaro, GJ; Lotti, VJ; Siegl, PK; Patchett, AA; Greenlee, WJ α-Phenoxyphenylacetic acid derived angiotensin II antagonists with low nanomolar AT1 /AT2 receptor subtype affinity (Part II) Bioorg Med Chem Lett 5: 1151 -1154 (1995) Judd, DB; Dowle, MD; Middlemiss, D; Scopes, DI; Ross, BC; Jack, TI; Pass, M; Tranquillini, E; Hobson, JE; Panchal, TA Bromobenzofuran-based non-peptide antagonists of angiotensin II: GR138950, a potent antihypertensive agent with high oral bioavailability. J Med Chem 37: 3108 -20 (1994) Edmunds, JJ; Klutchko, S; Hamby, JM; Bunker, AM; Connolly, CJ; Winters, RT; Quin, J; Sircar, I; Hodges, JC; Panek, RL Derivatives of 5-[[1-(4'-carboxybenzyl)imidazolyl]methylidene]hydantoins as orally active angiotensin II receptor antagonists. J Med Chem 38: 3759 -71 (1995) Beauchamp, HT; Chang, RS; Siegl, PK; Gibson, RE In vivo receptor occupancy of the angiotensin II receptor by nonpeptide antagonists: relationship to in vitro affinities and in vivo pharmacologic potency. J Pharmacol Exp Ther 272: 612 -8 (1995) Carini, DJ; Duncia, JV; Aldrich, PE; Chiu, AT; Johnson, AL; Pierce, ME; Price, WA; Santella, JB; Wells, GJ; Wexler, RR Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives. J Med Chem 34: 2525 -47 (1991) Walsh, TF; Fitch, KJ; Williams, DL; Murphy, KL; Nolan, NA; Pettibone, DJ; Chang, RS; O'Malley, SS; Clineschmidt, BV; Veber, DF; Greenlee, WJ Potent dual antagonists of endothelin and angiotensin II receptors derived from α-phenoxyphenylacetic acids (Part III) Bioorg Med Chem Lett 5: 1155 -1158 (1995) Tourwé, D; Tsiailanis, AD; Parisis, N; Hirmiz, B; Del Borgo, M; Aguilar, MI; Van der Poorten, O; Ballet, S; Widdop, RE; Tzakos, AG Using conformational constraints at position 6 of Angiotensin II to generate compounds with enhanced AT2R selectivity and proteolytic stability. Bioorg Med Chem Lett 43: (2021) Bühlmayer, P; Furet, P; Criscione, L; Gasparo, Md; Whitebread, S; Schmidlin, T; Lattmann, R; Wood, J Valsartan, a potent, orally active angiotensin II antagonist developed from the structurally new amino acid series Bioorg Med Chem Lett 4: 29 -34 (1994) Ries, UJ; Mihm, G; Narr, B; Hasselbach, KM; Wittneben, H; Entzeroth, M; van Meel, JC; Wienen, W; Hauel, NH 6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships. J Med Chem 36: 4040 -51 (1994) Zhang, J; Wang, JL; Zhou, ZM; Li, ZH; Xue, WZ; Xu, D; Hao, LP; Han, XF; Fei, F; Liu, T; Liang, AH Design, synthesis and biological activity of 6-substituted carbamoyl benzimidazoles as new nonpeptidic angiotensin II AT1 receptor antagonists. Bioorg Med Chem 20: 4208 -16 (2012) Wang, JL; Zhang, J; Zhou, ZM; Li, ZH; Xue, WZ; Xu, D; Hao, LP; Han, XF; Fei, F; Liu, T; Liang, AH Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists. Eur J Med Chem 49: 183 -90 (2012) Rosenström, U; Sköld, C; Lindeberg, G; Botros, M; Nyberg, F; Karlén, A; Hallberg, A Design, synthesis, and incorporation of a beta-turn mimetic in angiotensin II forming novel pseudopeptides with affinity for AT1 and AT2 receptors. J Med Chem 49: 6133 -7 (2006) Glinka, TW; de Laszlo, SE; Siegl, PK; Chang, RS; Kivlighn, SD; Schorn, TS; Faust, KA; Chen, TB; Zingaro, GJ; Lotti, VJ; Greenlee, WJ Development of angiotensin II antagonists with equipotent affinity for human AT1 and AT2 receptor subtypes. Bioorg Med Chem Lett 4: 2337 -2342 (1994) Tellew, JE; Baska, RA; Beyer, SM; Carlson, KE; Cornelius, LA; Fadnis, L; Gu, Z; Kunst, BL; Kowala, MC; Monshizadegan, H; Murugesan, N; Ryan, CS; Valentine, MT; Yang, Y; Macor, JE Discovery of 4'-[(imidazol-1-yl)methyl]biphenyl-2-sulfonamides as dual endothelin/angiotensin II receptor antagonists. Bioorg Med Chem Lett 13: 1093 -6 (2003) Choung, W; Jung, HJ; Nam, EH; Yang, D; Yoo, B; Choi, H; Lee, BR; Park, M; Jang, SM; Lim, JS; Kim, KH; Chin, J; Jung, K; Lee, G; Kim, SH Discovery of the bifunctional modulator of angiotensin II type 1 receptor (AT1R) and PPAR? derived from the AT1R antagonist, Fimasartan. Bioorg Med Chem Lett 28: 3155 -3160 (2018) Mantlo, NB; Kim, D; Ondeyka, D; Chang, RS; Kivlighn, SD; Siegl, PK; Greenlee, WJ Imidazo[4,5-b]pyridine-based AT1 / AT2 angiotensin II receptor antagonists Bioorg Med Chem Lett 4: 17 -22 (1994) Dhanoa, DS; Bagley, SW; Chang, RS; Lotti, VJ; Chen, TB; Kivlighn, SD; Zingaro, GJ; Siegl, PK; Patchett, AA; Greenlee, WJ Non-peptide angiotensin II receptor antagonists. 1. Design, synthesis, and biological activity of N-substituted indoles and dihydroindoles. J Med Chem 36: 4230 -8 (1994) Ashton, WT; Cantone, CL; Chang, LL; Hutchins, SM; Strelitz, RA; MacCoss, M; Chang, RS; Lotti, VJ; Faust, KA; Chen, TB Nonpeptide angiotensin II antagonists derived from 4H-1,2,4-triazoles and 3H-imidazo[1,2-b][1,2,4]triazoles. J Med Chem 36: 591 -609 (1993) Salimbeni, A; Canevotti, R; Paleari, F; Bonaccorsi, F; Renzetti, AR; Belvisi, L; Bravi, G; Scolastico, C Nonpeptide angiotensin II receptor antagonists. Synthesis, in vitro activity, and molecular modeling studies of N-[(heterobiaryl)methyl] imidazoles. J Med Chem 37: 3928 -38 (1994) Allen, EE; de Laszlo, SE; Huang, SX; Quagliato, CS; Greenlee, WJ; Chang, RS; Chen, TB; Faust, KA; Lotti, VJ Quinazolinones 1: design and synthesis of potent quinazolinone- containing AT1 -selective angiotensin-II receptor antagonists Bioorg Med Chem Lett 3: 1293 -1298 (1993) Kim, KS; Qian, L; Bird, JE; Dickinson, KE; Moreland, S; Schaeffer, TR; Waldron, TL; Delaney, CL; Weller, HN; Miller, AV Quinoxaline N-oxide containing potent angiotensin II receptor antagonists: synthesis, biological properties, and structure-activity relationships. J Med Chem 36: 2335 -42 (1993) Kevin, NJ; Rivero, RA; Greenlee, WJ; Chang, RS; Chen, TB Subtituted phenylthiophene benzoylsulfonamides with potent binding affinity to angiotensin II AT1 and AT2 receptors Bioorg Med Chem Lett 4: 189 -194 (1994) Guo, XZ; Shi, L; Wang, R; Liu, XX; Li, BG; Lu, XX Synthesis and biological activities of novel nonpeptide angiotensin II receptor antagonists based on benzimidazole derivatives bearing a heterocyclic ring. Bioorg Med Chem 16: 10301 -10 (2008) Xu, JY; Zeng, Y; Ran, Q; Wei, Z; Bi, Y; He, QH; Wang, QJ; Hu, S; Zhang, J; Tang, MY; Hua, WY; Wu, XM Synthesis and biological activity of 2-alkylbenzimidazoles bearing a N-phenylpyrrole moiety as novel angiotensin II AT1 receptor antagonists. Bioorg Med Chem Lett 17: 2921 -6 (2007) Ashton, WT; Chang, LL; Flanagan, KL; Hutchins, SM; Naylor, EM; Chakravarty, PK; Patchett, AA; Greenlee, WJ; Chen, TB; Faust, KA Triazolinone biphenylsulfonamide derivatives as orally active angiotensin II antagonists with potent AT1 receptor affinity and enhanced AT2 affinity. J Med Chem 37: 2808 -24 (1994) Rosenström, U; Sköld, C; Lindeberg, G; Botros, M; Nyberg, F; Karlén, A; Hallberg, A A selective AT2 receptor ligand with a gamma-turn-like mimetic replacing the amino acid residues 4-5 of angiotensin II. J Med Chem 47: 859 -70 (2004) Hill, DT; Girard, GR; Weinstock, J; Edwards, RM; Weidley, EF; Ohlstein, E; Peishoff, CE; Baker, E; Aiyar, N D and L-N-[(1-benzyl-1H-imidazol-5-yl)-alkyl]-amino acids as angiotensin II AT-1 antagonists Bioorg Med Chem Lett 5: 19 -24 (1995) Keenan, RM; Weinstock, J; Finkelstein, JA; Franz, RG; Gaitanopoulos, DE; Girard, GR; Hill, DT; Morgan, TM; Samanen, JM; Hempel, J Imidazole-5-acrylic acids: potent nonpeptide angiotensin II receptor antagonists designed using a novel peptide pharmacophore model. J Med Chem 35: 3858 -72 (1992) Bantick, JR; Beaton, HG; Cooper, SL; Hill, S; Hirst, SC; McInally, T; Spencer, J; Tinker, AC; Willis, PA New non-peptide angiotensin II receptor antagonists. 2: structure - activity relationship of a series of annelated 2(1H)-pyridinones Bioorg Med Chem Lett 4: 127 -132 (1994) Ashton, WT; Hutchins, SM; Greenlee, WJ; Doss, GA; Chang, RS; Lotti, VJ; Faust, KA; Chen, TB; Zingaro, GJ; Kivlighn, SD Nonpeptide angiotensin II antagonists derived from 1H-pyrazole-5-carboxylates and 4-aryl-1H-imidazole-5-carboxylates. J Med Chem 36: 3595 -605 (1994) Ono, K; Ueda, H; Yoshizawa, Y; Akazawa, D; Tanimura, R; Shimada, I; Takahashi, H Structural basis for platelet antiaggregation by angiotensin II type 1 receptor antagonist losartan (DuP-753) via glycoprotein VI. J Med Chem 53: 2087 -93 (2010) Mohan, R; Chou, YL; Bihovsky, R; Lumma, WC; Erhardt, PW; Shaw, KJ Synthesis and biological activity of angiotensin II analogues containing a Val-His replacement, Val psi[CH(CONH2)NH]His. J Med Chem 34: 2402 -10 (1991) Wu, MT; Ikeler, TJ; Ashton, WT; Chang, RS; Lotti, VJ; Greenlee, WJ Synthesis and structure-activity relationships of a novel series of non-peptide AT2 -selective angiotensin II receptor antagonists Bioorg Med Chem Lett 3: 2023 -2028 (1993) Blankley, CJ; Hodges, JC; Klutchko, SR; Himmelsbach, RJ; Chucholowski, A; Connolly, CJ; Neergaard, SJ; Van Nieuwenhze, MS; Sebastian, A; Quin, J Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype. J Med Chem 34: 3248 -60 (1991) de Laszlo, SE; Glinka, TW; Greenlee, WJ; Ball, R; Nachbar, RB; Prendergast, K The design, binding affinity prediction and synthesis of macrocyclic angiotensin II AT1 and AT2 receptor antagonists Bioorg Med Chem Lett 6: 923 -928 (1996) Thomas, AP; Allott, CP; Gibson, KH; Major, JS; Masek, BB; Oldham, AA; Ratcliffe, AH; Roberts, DA; Russell, ST; Thomason, DA New nonpeptide angiotensin II receptor antagonists. 1. Synthesis, biological properties, and structure-activity relationships of 2-alkyl benzimidazole derivatives. J Med Chem 35: 877 -85 (1992) Chang, LL; Ashton, WT; Flanagan, KL; Rivero, RA; Chen, TB; O'Malley, SS; Zingaro, GJ; Kivlighn, SD; Siegl, PK; Lotti, VJ; Chang, RS; Greenlee, WJ Potent triazolinone-based angiotensin II receptor antagonists with equivalent affinity for both the AT1 and AT2 subtypes Bioorg Med Chem Lett 4: 2787 -2792 (1994) Schmidt, B; Lindman, S; Tong, W; Lindeberg, G; Gogoll, A; Lai, Z; Thörnwall, M; Synnergren, B; Nilsson, A; Welch, CJ; Sohtell, M; Westerlund, C; Nyberg, F; Karlén, A; Hallberg, A Design, synthesis, and biological activities of four angiotensin II receptor ligands with gamma-turn mimetics replacing amino acid residues 3-5. J Med Chem 40: 903 -19 (1997) Cappelli, A; Nannicini, C; Gallelli, A; Giuliani, G; Valenti, S; Mohr, Gl; Anzini, M; Mennuni, L; Ferrari, F; Caselli, G; Giordani, A; Peris, W; Makovec, F; Giorgi, G; Vomero, S Design, synthesis, and biological evaluation of AT1 angiotensin II receptor antagonists based on the pyrazolo[3,4-b]pyridine and related heteroaromatic bicyclic systems. J Med Chem 51: 2137 -46 (2008) Casimiro-Garcia, A; Filzen, GF; Flynn, D; Bigge, CF; Chen, J; Davis, JA; Dudley, DA; Edmunds, JJ; Esmaeil, N; Geyer, A; Heemstra, RJ; Jalaie, M; Ohren, JF; Ostroski, R; Ellis, T; Schaum, RP; Stoner, C Discovery of a series of imidazo[4,5-b]pyridines with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-¿. J Med Chem 54: 4219 -33 (2011) PubChem, PC Dose Response screen for agonists of Angiotensin II Receptor Type 1 to assess selectivity of uHTS small molecule agonists hits of the APJ receptor PubChem Bioassay (2010) PubChem, PC Dose Response screen for antagonists of Angiotensin II Receptor Type 1 to assess selectivity of uHTS small molecule antagonists hits of the APJ receptor PubChem Bioassay (2010) Dhanoa, DS; Bagley, SW; Chang, RS; Lotti, VJ; Chen, TB; Kivlighn, SD; Zingaro, GJ; Siegl, PK; Patchett, AA; Greenlee, WJ Non-peptide angiotensin II receptor antagonists. 2. Design, synthesis, and biological activity of N-substituted (phenylamino)phenylacetic acids and acyl sulfonamides. J Med Chem 36: 4239 -49 (1994) Deprez, P; Guillaume, J; Becker, R; Corbier, A; Didierlaurent, S; Fortin, M; Frechet, D; Hamon, G; Heckmann, B; Heitsch, H Sulfonylureas and sulfonylcarbamates as new non-tetrazole angiotensin II receptor antagonists. Discovery of a highly potent orally active (imidazolylbiphenylyl)sulfonylurea (HR 720). J Med Chem 38: 2357 -77 (1995) Kim, TW; Yoo, BW; Lee, JK; Kim, JH; Lee, KT; Chi, YH; Lee, JY Synthesis and antihypertensive activity of pyrimidin-4(3H)-one derivatives as losartan analogue for new angiotensin II receptor type 1 (AT1) antagonists. Bioorg Med Chem Lett 22: 1649 -54 (2012) Bai, R; Wei, Z; Liu, J; Xie, W; Yao, H; Wu, X; Jiang, J; Wang, Q; Xu, J Synthesis and biological evaluation of 4'-[(benzimidazole-1-yl)methyl]biphenyl-2-sulfonamide derivatives as dual angiotensin II/endothelin A receptor antagonists. Bioorg Med Chem 20: 4661 -7 (2012) Handa, RK; Harding, JW; Simasko, SM Characterization and function of the bovine kidney epithelial angiotensin receptor subtype 4 using angiotensin IV and divalinal angiotensin IV as receptor ligands. J Pharmacol Exp Ther 291: 1242 -9 (1999) Glinka, TW; de Laszlo, SE; Siegl, PK; Chang, RS; Kivlighn, SD; Schorn, TS; Faust, KA; Chen, TB; Zingaro, GJ; Lotti, VJ; Greenlee, WJ A new class of balanced AT1 /AT2 angiotensin II antagonists: quinazolinone AII antagonists with acylsulfonamide and sulfonylcarbamate acidic functionalities Bioorg Med Chem Lett 4: 81 -86 (1994) Quan, ML; Olson, RE; Carini, DJ; Ellis, CD; Hillyer, GL; Lalka, GK; Liu, J; VanAtten, MK; Chiu, AT; Wong, PC; Wexler, RR; Timmermans, PB Balanced angiotensin II receptor antagonists. I. The effects of biphenyl “ortho”-substitution on AT1 /AT2 affinities Bioorg Med Chem Lett 4: 2011 -2016 (1994) Cappelli, A; Pericot Mohr Gl, G; Gallelli, A; Rizzo, M; Anzini, M; Vomero, S; Mennuni, L; Ferrari, F; Makovec, F; Menziani, MC; De Benedetti, PG; Giorgi, G Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT(1) angiotensin II receptor antagonists based on the 4-phenylquinoline structure. J Med Chem 47: 2574 -86 (2004) Bradbury, RH; Allott, CP; Dennis, M; Fisher, E; Major, JS; Masek, BB; Oldham, AA; Pearce, RJ; Rankine, N; Revill, JM New nonpeptide angiotensin II receptor antagonists. 2. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4-(biphenylylmethoxy)quinoline derivatives. J Med Chem 35: 4027 -38 (1992) Bradbury, RH; Allott, CP; Dennis, M; Girdwood, JA; Kenny, PW; Major, JS; Oldham, AA; Ratcliffe, AH; Rivett, JE; Roberts, DA New nonpeptide angiotensin II receptor antagonists. 3. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4-(biphenylylmethoxy)pyridine derivatives. J Med Chem 36: 1245 -54 (1993) Rosenström, U; Sköld, C; Plouffe, B; Beaudry, H; Lindeberg, G; Botros, M; Nyberg, F; Wolf, G; Karlén, A; Gallo-Payet, N; Hallberg, A New selective AT2 receptor ligands encompassing a gamma-turn mimetic replacing the amino acid residues 4-5 of angiotensin II act as agonists. J Med Chem 48: 4009 -24 (2005) Rivero, RA; Greenlee, WJ; Chang, RS Substituted 1,3-benzodioxole & 1,3-benzodithiole -2- carboxylates and their tetrazole analogs with potent binding affinity to the angiotensin II AT1 receptor Bioorg Med Chem Lett 4: 747 -750 (1994) Chakravarty, PK; Naylor, EM; Chen, A; Chang, RS; Chen, TB; Faust, KA; Lotti, VJ; Kivlighn, SD; Gable, RA; Zingaro, GJ A highly potent, orally active imidazo[4,5-b]pyridine biphenylacylsulfonamide (MK-996; L-159,282): a new AT1-selective angiotensin II receptor antagonist. J Med Chem 37: 4068 -72 (1995) Rivero, RA; Kevin, NJ; Kivlighn, SD; Zingaro, GJ; Chang, RS; Greenlee, WJ L-162,389: a potent orally active angiotensin II receptor antagonist with balanced affinity to both AT1 and AT2 receptor subtypes Bioorg Med Chem Lett 6: 307 -310 (1996) Agelis, G; Resvani, A; Koukoulitsa, C; T?mová, T; Slaninová, J; Kalavrizioti, D; Spyridaki, K; Afantitis, A; Melagraki, G; Siafaka, A; Gkini, E; Megariotis, G; Grdadolnik, SG; Papadopoulos, MG; Vlahakos, D; Maragoudakis, M; Liapakis, G; Mavromoustakos, T; Matsoukas, J Rational design, efficient syntheses and biological evaluation of N,N'-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers. Eur J Med Chem 62: 352 -70 (2013) Cappelli, A; Pericot Mohr, G; Giuliani, G; Galeazzi, S; Anzini, M; Mennuni, L; Ferrari, F; Makovec, F; Kleinrath, EM; Langer, T; Valoti, M; Giorgi, G; Vomero, S Further studies on imidazo[4,5-b]pyridine AT1 angiotensin II receptor antagonists. Effects of the transformation of the 4-phenylquinoline backbone into 4-phenylisoquinolinone or 1-phenylindene scaffolds. J Med Chem 49: 6451 -64 (2006) Mederski, WW; Dorsch, D; Bokel, HH; Beier, N; Lues, I; Schelling, P Non-peptide angiotensin II receptor antagonists: synthesis and biological activity of a series of novel 4,5-dihydro-4-oxo-3H-imidazo[4,5-c]pyridine derivatives. J Med Chem 37: 1632 -45 (1994) Liang, Q; He, J; Zhao, X; Xue, Y; Zuo, H; Xu, R; Jin, Y; Wang, J; Li, Q; Zhao, X Selective Discovery of GPCR Ligands within DNA-Encoded Chemical Libraries Derived from Natural Products: A Case Study on Antagonists of Angiotensin II Type I Receptor. J Med Chem 64: 4196 -4205 (2021) Casimiro-Garcia, A; Heemstra, RJ; Bigge, CF; Chen, J; Ciske, FA; Davis, JA; Ellis, T; Esmaeil, N; Flynn, D; Han, S; Jalaie, M; Ohren, JF; Powell, NA Design, synthesis, and evaluation of imidazo[4,5-c]pyridin-4-one derivatives with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-¿. Bioorg Med Chem Lett 23: 767 -72 (2013) Han, XF; He, X; Wang, M; Xu, D; Hao, LP; Liang, AH; Zhang, J; Zhou, ZM Discovery of novel, potent and low-toxicity angiotensin II receptor type 1 (AT1) blockers: Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazoles with a chiral center. Eur J Med Chem 103: 473 -87 (2015) Agelis, G; Resvani, A; Durdagi, S; Spyridaki, K; Tumová, T; Slaninová, J; Giannopoulos, P; Vlahakos, D; Liapakis, G; Mavromoustakos, T; Matsoukas, J The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: a concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivatives. Eur J Med Chem 55: 358 -74 (2012) Maletínská, L; Neugebauer, W; Pérodin, J; Lefebvre, M; Escher, E Angiotensin analogues palmitoylated in positions 1 and 4. J Med Chem 40: 3271 -9 (1997) Watthey, JW; Gavin, T; Desai, M Bicyclic lactam inhibitors of angiotensin converting enzyme. J Med Chem 27: 816 -8 (1984) Yanagisawa, H; Amemiya, Y; Kanazaki, T; Shimoji, Y; Fujimoto, K; Kitahara, Y; Sada, T; Mizuno, M; Ikeda, M; Miyamoto, S; Furukawa, Y; Koike, H Nonpeptide angiotensin II receptor antagonists: synthesis, biological activities, and structure-activity relationships of imidazole-5-carboxylic acids bearing alkyl, alkenyl, and hydroxyalkyl substituents at the 4-position and their related compounds. J Med Chem 39: 323 -38 (1996) Lin, HS; Rampersaud, AA; Zimmerman, K; Steinberg, MI; Boyd, DB Nonpeptide angiotensin II receptor antagonists: synthetic and computational chemistry of N-[[4-[2-(2H-tetrazol-5-yl)-1-cycloalken-1- yl]phenyl]methyl]imidazole derivatives and their in vitro activity. J Med Chem 35: 2658 -67 (1992) Kiyama, R; Honma, T; Hayashi, K; Ogawa, M; Hara, M; Fujimoto, M; Fujishita, T Novel angiotensin II receptor antagonists. Design, synthesis, and in vitro evaluation of dibenzo[a,d]cycloheptene and dibenzo[b,f]oxepin derivatives. Searching for bioisosteres of biphenylyltetrazole using a three-dimensional search technique. J Med Chem 38: 2728 -41 (1995) Menard, PR; Suh, JT; Jones, H; Loev, B; Neiss, ES; Wilde, J; Schwab, A; Mann, WS Angiotensin converting enzyme inhibitors. (Mercaptoaroyl)amino acids. J Med Chem 28: 328 -32 (1985) Slade, J; Stanton, JL; Ben-David, D; Mazzenga, GC Angiotensin converting enzyme inhibitors: 1,5-benzothiazepine derivatives. J Med Chem 28: 1517 -21 (1985) Meyer, RF; Essenburg, AD; Smith, RD; Kaplan, HR Angiotensin converting enzyme inhibitors: modifications of a tripeptide analogue. J Med Chem 25: 996 -9 (1982) Smith, EM; Swiss, GF; Neustadt, BR; McNamara, P; Gold, EH; Sybertz, EJ; Baum, T Angiotensin converting enzyme inhibitors: spirapril and related compounds. J Med Chem 32: 1600 -6 (1989) Lukaszuk, A; Demaegdt, H; Szemenyei, E; Tóth, G; Tymecka, D; Misicka, A; Karoyan, P; Vanderheyden, P; Vauquelin, G; Tourwé, D Beta-homo-amino acid scan of angiotensin IV. J Med Chem 51: 2291 -6 (2008) Ksander, GM; Erion, M; Yuan, AM; Diefenbacher, CG; el-Chehabi, L; Cote, D; Levens, N Dual angiotensin converting enzyme/thromboxane synthase inhibitors. J Med Chem 37: 1823 -32 (1994) Ghosh, SS; Said-Nejad, O; Roestamadji, J; Mobashery, S The first mechanism-based inactivators for angiotensin-converting enzyme. J Med Chem 35: 4175 -9 (1992) Dounay, AB; McAllister, L; Parikh, VD; Rong, S; Verhoest, PR KAT II inhibitors US Patent US8598200 (2013) Gabriel, SD; Thomas, A Triazole compounds II US Patent US8697696 (2014) Thorsett, ED; Harris, EE; Aster, SD; Peterson, ER; Snyder, JP; Springer, JP; Hirshfield, J; Tristram, EW; Patchett, AA; Ulm, EH Conformationally restricted inhibitors of angiotensin converting enzyme: synthesis and computations. J Med Chem 29: 251 -60 (1986) Ondetti, MA; Cushman, DW Inhibition of the renin-angiotensin system. A new approach to the therapy of hypertension. J Med Chem 24: 355 -61 (1981) Keiser, JA; Ryan, MJ; Panek, RL; Hodges, JC; Sircar, I Pharmacologic characterization of CI-996, a new angiotensin receptor antagonist. J Pharmacol Exp Ther 272: 963 -9 (1995) Hodges, JC; Edmunds, JJ; Nordblom, GD; Lu, GH The syntheses and binding affinities of tools for the study of angiotensin AT2 receptors Bioorg Med Chem Lett 3: 905 -908 (1993) Walsh, TF; Fitch, KJ; MacCoss, M; Chang, RS; Kivlighn, SD; Lotti, VJ; Siegl, PK; Patchett, AA; Greenlee, WJ Synthesis of new imidazo[1,2-b ]pyridazine isosteres of potent imidazo[4,5-b ]pyridine angiotensin II antagonists Bioorg Med Chem Lett 4: 219 -222 (1994) Mountford, SJ; Zheng, Z; Sundaram, K; Jennings, IG; Hamilton, JR; Thompson, PE Class II but Not Second Class-Prospects for the Development of Class II PI3K Inhibitors. ACS Med Chem Lett 6: 3 -6 (2015) Yanagisawa, H; Ishihara, S; Ando, A; Kanazaki, T; Miyamoto, S; Koike, H; Iijima, Y; Oizumi, K; Matsushita, Y; Hata, T Angiotensin-converting enzyme inhibitors. 2. Perhydroazepin-2-one derivatives. J Med Chem 31: 422 -8 (1988) Andrews, PR; Carson, JM; Caselli, A; Spark, MJ; Woods, R Conformational analysis and active site modelling of angiotensin-converting enzyme inhibitors. J Med Chem 28: 393 -9 (1985) Roark, WH; Tinney, FJ; Cohen, D; Essenburg, AD; Kaplan, HR Synthesis and biological activity of modified peptide inhibitors of angiotensin-converting enzyme. J Med Chem 28: 1291 -5 (1985) Hayashi, K; Nunami, K; Kato, J; Yoneda, N; Kubo, M; Ochiai, T; Ishida, R Studies on angiotensin converting enzyme inhibitors. 4. Synthesis and angiotensin converting enzyme inhibitory activities of 3-acyl-1-alkyl-2-oxoimidazolidine-4-carboxylic acid derivatives. J Med Chem 32: 289 -97 (1989)
Ivanov, AA; Baskin, II; Palyulin, VA; Piccagli, L; Baraldi, PG; Zefirov, NS J Med Chem 48: 6813 -20 (2005) da Silva, Fde C; de Souza, MC; Frugulhetti, II; Castro, HC; Souza, SL; de Souza, TM; Rodrigues, DQ; Souza, AM; Abreu, PA; Passamani, F; Rodrigues, CR; Ferreira, VF Eur J Med Chem 44: 373 -83 (2009) Ii, K; Ichikawa, S; Al-Dabbagh, B; Bouhss, A; Matsuda, A J Med Chem 53: 3793 -813 (2010) Jevti?, II; Suru?i?, RV; Tovilovi?-Kova?evi?, G; Zogovi?, N; Kosti?-Raja?i?, SV; Andri?, DB; Penji?evi?, JZ Bioorg Med Chem 101: (2024) Plyasova, AA; Berrino, E; Khan, II; Veselovsky, AV; Pokrovsky, VS; Angeli, A; Ferraroni, M; Supuran, CT; Pokrovskaya, MV; Alexandrova, SS; Gladilina, YA; Sokolov, NN; Hilal, A; Carta, F; Zhdanov, DD J Med Chem 64: 11432 -11444 (2021) Yagupolskii, LM; Antepohl, W; Artunc, F; Handrock, R; Klebanov, BM; Maletina, II; Marxen, B; Petko, KI; Quast, U; Vogt, A; Weiss, C; Zibold, J; Herzig, S J Med Chem 42: 5266 -71 (1999) Protasevich, II; Brouillette, CG; Snow, ME; Dunham, S; Rubin, JR; Gogliotti, R; Siegel, K Biochemistry 43: 13380 -9 (2004) Boutin, R; Lee, HF; Guan, TL; Nguyen, TT; Huang, XF; Waller, DD; Lu, J; Christine Chio, II; Michel, RP; Sebag, M; Tsantrizos, YS J Med Chem 66: 15776 -15800 (2023) Tang, H; Pio, B; Jiang, J; Pasternak, A; Dong, S; Ferguson, II, RD; Guo, ZZ; Chobanian, H; Frie, J; Guo, Y; Wu, Z; Yu, Y; Wang, M US Patent US9751881 (2017) Greiner, E; Prisinzano, T; Johnson II, EM; Dersch, CM; Marcus, J; Partilla, JS; Rothman, RB; Jacobson, AE; Rice, KC J Med Chem 46: 1465 -9 (2003) Miller, II, MM; Allen, MP; Li, L US Patent US11492375 (2022) Alghamdi, SS; Mustafa, SM; Moore Ii, BM Bioorg Med Chem 33: (2021) Moore, II, BM; Bhattacharjee, H; Mustafa, S US Patent US9139546 (2015) Adams, JA; Bechle, BM; Dutra, JK; Garnsey, MR; Hou, X; Lee, J; Nason, II, DM; O''Neil, SV; Rankic, DA; Wang, Y; Wright, AS; Zhang, L; Zhang, L; Edmonds, DJ US Patent US20240150334 (2024) Soriano-Ursúa, MA; Arias-Montaño, JA; Correa-Basurto, J; Hernández-Martínez, CF; López-Cabrera, Y; Castillo-Hernández, MC; Padilla-Martínez, II; Trujillo-Ferrara, JG Bioorg Med Chem Lett 25: 820 -5 (2015) Evarts, J; Kaplan, J; Kim, M; Naduthambi, D; Patel, L; Perreault, S; Phillips, G; Purvis, II, LJ; Stevens, KL; Treiberg, JA US Patent US9765060 (2017) Dilger, AK; Corte, JR; De Lucca, I; Fang, T; Yang, W; Wang, Y; Pabbisetty, KB; Ewing, WR; Zhu, Y; Wexler, RR; Pinto, DJ; Orwat, MJ; Smith, II, LM US Patent US10336754 (2019)
ChEBML_36936 Inhibition of angiotensin Angiotensin II receptor, type 1 in rabbit aorta using [125I-Sar1,Ile8] angiotensin II binding assay ChEBML_34826 Inhibition of [125I]angiotensin-II binding to the angiotensin II receptor type 1 in rat uterine membranes ChEBML_34973 Inhibitory concentration against binding of [125I]angiotensin II to rat liver expressing Angiotensin II receptor ChEMBL_36176 (CHEMBL876744) Displacement of monoiodinated angiotensin II from guinea-pig adrenal gland angiotensin II receptor ChEMBL_36936 (CHEMBL650271) Inhibition of angiotensin Angiotensin II receptor, type 1 in rabbit aorta using [125I-Sar1,Ile8] angiotensin II binding assay ChEMBL_34973 (CHEMBL649502) Inhibitory concentration against binding of [125I]angiotensin II to rat liver expressing Angiotensin II receptor ChEMBL_36483 (CHEMBL651552) Inhibition of radioligand [3H]angiotensin II binding to angiotensin II receptor of rat adrenal cortical membrane ChEMBL_2303164 Inhibition of angiotensin II (unknown origin) ChEMBL_34810 (CHEMBL648954) Displacement of [125-I]-labeled angiotensin II from Angiotensin II receptor, type 1 of rat uterine membranes ChEMBL_34944 (CHEMBL647787) Inhibition of [125I]Sar1,Ile8 angiotensin II binding to Angiotensin II receptor type 1 in rat adrenocortical membrane ChEMBL_35116 (CHEMBL647025) Inhibition of [3H]angiotensin II binding to rat adrenal cortex membrane containing angiotensin II receptor, type 1 ChEBML_34679 Inhibition of Angiotensin II receptor, type 1 ChEBML_35562 Binding affinity for angiotensin II AT-2 receptor ChEMBL_2303161 Inhibition of rat adrenal cortex angiotensin II ChEBML_35110 Binding affinity for Angiotensin II receptor, type 1 in rat adrenal cortical membranes using [125I]Sar1, Ile8-angiotensin II ChEBML_36933 Evaluation of Angiotensin II antagonistic activity by displacement of [125I]-Sar Ile-AII at the rabbit aorta Angiotensin II receptor, type 1 ChEMBL_35289 (CHEMBL647853) Inhibition of Angiotensin II receptor, type 2 in rat midbrain using [125I]-Sar1,Ile8 angiotensin II binding assay ChEMBL_36174 (CHEMBL646986) Inhibition of [3-[125I]-iodotyrosyl]-angiotensin II binding to Angiotensin II receptors in the membrane preparations of guinea pig adrenal glands. ChEMBL_36935 (CHEMBL650270) Inhibition of Angiotensin II receptor, type 1 in rabbit aorta using [125I-Sar1,Ile8] angiotensin II binding assay ChEBML_217980 In vitro antagonistic potency against angiotensin II receptor using [125I]- Sar,Ile8-angiotensin II as the radioligand in rat adrenal cortical membranes ChEMBL_2291728 Displacement of [125I]-Angiotensin II from Angiotensin II type-1 receptor in VSMC cells (unknown origin) by competition radioligand binding assay ChEMBL_34811 (CHEMBL648955) Binding affinity towards Angiotensin II receptor, type 1 in rat liver membrane using [125I]-angiotensin II (0.1 nM) ChEMBL_35110 (CHEMBL649312) Binding affinity for Angiotensin II receptor, type 1 in rat adrenal cortical membranes using [125I]Sar1, Ile8-angiotensin II ChEMBL_35261 (CHEMBL648567) Displacement of [125I]- Ang II from type 1 Angiotensin II receptor ChEBML_35129 Binding affinity for Angiotensin II receptor, type 1 ChEMBL_34648 (CHEMBL649707) Inhibition of Angiotensin II receptor, type 1 ChEMBL_35254 (CHEMBL647575) Inhibition of Angiotensin II receptor, type 1 ChEMBL_35421 (CHEMBL643595) Inhibition of Angiotensin II receptor, type 2 ChEMBL_36497 (CHEMBL652611) Inhibitory activity against Angiotensin II receptor ChEMBL_714772 (CHEMBL1663578) Inhibition of human angiotensin II AT1 receptor ChEMBL_714773 (CHEMBL1663579) Inhibition of human angiotensin II AT2 receptor ChEMBL_217980 (CHEMBL824099) In vitro antagonistic potency against angiotensin II receptor using [125I]- Sar,Ile8-angiotensin II as the radioligand in rat adrenal cortical membranes ChEMBL_34833 (CHEMBL648767) Binding affinity for Angiotensin II receptor, type 1 determined using [125I]- labeled [Sar1,Ile8] angiotensin II in rat adrenocortical membranes ChEMBL_36773 (CHEMBL650295) In vitro for inhibition of [125I]-angiotensin II (0.1 nM) binding to angiotensin II receptor type 1 in membrane fractions of bovine adrenal cortex ChEBML_34803 Activity against high affinity Angiotensin II receptor, type 1 was measured from the ability to inhibit [125I]angiotensin II binding to rat uterine membrane. ChEBML_35283 Activity against low affinity Angiotensin II receptor, type 2 was measured from the ability to inhibit [125I]angiotensin II binding to rat uterine membrane ChEMBL_36330 (CHEMBL650157) Binding against Angiotensin II receptor in a radioligand binding assay using [125I]-Sar1-Ile8 angiotensin-II as radioligand in rat adrenal cortical membranes ChEMBL_36469 (CHEMBL653122) Angiotensin II receptor antagonist activity was determined by 50% inhibition of specific binding of [3H]angiotensin II (2 nM) to rat adrenal cortical microsomes ChEMBL_36796 (CHEMBL650316) Tested for inhibition of Angiotensin II specific binding to Angiotensin II receptor, type 1 in the recombinant human AT-1 receptor expressed in LhAT-1D6 cells ChEMBL_34819 (CHEMBL648963) Inhibition of specific binding of [125I]angiotensin-II to angiotensin 1 receptor in rat lung membrane preparation ChEMBL_36646 (CHEMBL652356) In vitro displacement of [125I]angiotensin II from rat liver (Angiotensin 1 receptor) membrane preparation ChEMBL_36651 (CHEMBL649911) In vitro displacement of [125I]angiotensin II from angiotensin 2 receptor on rabbit uterus membrane preparation ChEMBL_940612 (CHEMBL2327554) Displacement of [125I]Tyr4-Sar1,Ile8-Angiotensin II from human Angiotensin 1 receptor after ChEMBL_1560582 (CHEMBL3777314) Binding affinity to angiotensin II receptor (unknown origin) ChEMBL_34658 (CHEMBL649717) Binding affinity to Angiotensin II receptor, type 1 ChEMBL_35415 (CHEMBL643589) Inhibitory activity at Angiotensin II type 2 receptor. ChEMBL_35418 (CHEMBL643592) Binding affinity to Angiotensin II receptor, type 2 ChEMBL_36338 (CHEMBL650165) Binding affinity for rat brain Angiotensin II receptor ChEMBL_36498 (CHEMBL652612) Inhibitory activity against Angiotensin II receptor was determined ChEMBL_2291729 Displacement of [125I]-Angiotensin II from Angiotensin II type-1 receptor in VSMC cells (unknown origin) assessed as inhibition constant by competition radioligand binding assay ChEBML_35434 Displacement of [125I]- Ang II from angiotensin II AT2 receptor in rat adrenal cortical microsomes ChEMBL_36941 (CHEMBL648844) Displacement of [125I]-Sar1-Ile8-A II at the rabbit aorta angiotensin II receptor, type 1 ChEMBL_36175 (CHEMBL646987) Concentration required for 50% displacement of the specifically bound [3-[125I]-iodotyrosyl]-angiotensin II from angiotensin II receptor in the membrane preparations of guinea pig adrenal glands ChEBML_34813 Inhibition of [125I]angiotensin II specific binding to rat mesenteric arteries ChEBML_35563 In vitro binding affinity of compound against angiotensin II AT-2 receptor ChEBML_36154 Binding affinity against angiotensin II receptor from rat liver ChEBML_36166 In vitro binding affinity to angiotensin II receptor in bovine adrenal cortex ChEBML_36169 In vitro Angiotensin II receptor antagonism in bovine adrenal cortex tissue. ChEMBL_321233 (CHEMBL881768) Inhibitory concentration against angiotensin II receptor, type 1 ChEMBL_321234 (CHEMBL881769) Inhibitory concentration against angiotensin II receptor, type 2 ChEMBL_34817 (CHEMBL648961) Binding affinity for rat angiotensin II receptor, type 1 ChEMBL_35259 (CHEMBL648565) Tested for binding affinity to Angiotensin II receptor, type 1 ChEMBL_35560 (CHEMBL645745) Inhibition of rat midbrain angiotensin II type 2 receptor ChEMBL_35564 (CHEMBL647512) In vitro binding affinity against angiotensin II AT-2 receptor ChEMBL_36164 (CHEMBL646976) Binding affinity for angiotensin II receptor of bovine adrenal cortex ChEMBL_36326 (CHEMBL650859) Inhibition of Angiotensin II induced contractions in rabbit aortic rings ChEBML_35284 Inhibition of [125I]-Sar1-Ile8-Ang II binding to rat midbrain Angiotensin II receptor type 2 ChEMBL_303241 (CHEMBL827206) Displacement of [125I]-Ang II from angiotensin II receptor type 2 in pig uterus myometrium ChEMBL_34956 (CHEMBL647799) Displacement of [125I]- Ang II from angiotensin II AT1 receptor in rat adrenal cortical microsomes ChEMBL_35416 (CHEMBL643590) Inhibitory concentration against Angiotensin II receptor type 2 with [125I]-[Sar1,Ile8]Ang II ChEMBL_35417 (CHEMBL643591) Inhibition of [125I]-[Sar1,Ile8]Ang II binding at rat angiotensin II (type 2) receptor. ChEMBL_35111 (CHEMBL649313) Binding affinity towards Angiotensin II receptor, type 1 in rat aortic smooth muscle cells using 0.2 nM [125I]-labeled Sar-Ile-angiotensin II ChEBML_36930 Inhibition of [125I]-Sar1-Ile8-Ang II binding to Angiotensin II receptor type 1 from rabbit aorta ChEMBL_303611 (CHEMBL829700) Displacement of [125I]-Ang II from pig uterus membrane angiotensin II type 2 (AT2) receptor ChEMBL_303706 (CHEMBL829041) Displacement of [125I]-Ang II from pig uterus myometrium angiotensin II type 2 (AT2) receptor ChEMBL_306794 (CHEMBL832379) Displacement of [125I]-Ang II from pig uterus membrane angiotensin II type 2 (AT2) receptor ChEMBL_35277 (CHEMBL647776) Binding affinity for Angiotensin II receptor type 2 using [125I]- Ang II in pig uterus myometrium ChEMBL_36780 (CHEMBL650301) Inhibition of [125I]angiotensin binding to a guinea pig adrenal membrane preparation which corresponds to Angiotensin II receptor, type 1 ChEBML_34812 Compound was evaluated for the inhibition of Angiotensin II receptor induced vasoconstriction of the rabbit aorta ChEBML_35253 In vitro binding affinity of compound against Angiotensin II receptor, type 1 ChEBML_35279 In vitro binding affinity at angiotensin II (type 2) receptor in rabbit uterus. ChEBML_36623 Tested for binding affinity against angiotensin II receptor in rat adrenal cortex ChEBML_36640 Tested for binding affinity against angiotensin II receptor in rat adrenal cortex ChEMBL_35255 (CHEMBL647576) Tested for Angiotensin II receptor, type 1 affinity in the absence of BSA ChEMBL_35265 (CHEMBL648571) Binding affinity was determined against Angiotensin II receptor, type 1 ChEMBL_35266 (CHEMBL648572) Ki value was evaluated against Angiotensin II receptor, type 1 ChEMBL_35280 (CHEMBL647844) Inhibitory activity was evaluated against Angiotensin II receptor, type 2 ChEMBL_35290 (CHEMBL647854) Inhibitory activity against Angiotensin II receptor, type 2 binding ChEMBL_35419 (CHEMBL643593) Receptor binding affinity for Angiotensin II receptor, type 2 determined ChEMBL_35424 (CHEMBL643598) Ki value was evaluated against Angiotensin II receptor, type 2 ChEMBL_36329 (CHEMBL650156) Binding affinity against Angiotensin II receptor, from rat brain ChEMBL_36635 (CHEMBL652346) In vitro binding affinity for angiotensin II AT1 receptor in rabbit aorta ChEMBL_36656 (CHEMBL649916) In vitro binding affinity for angiotensin II AT2 receptor in rat midbrain ChEMBL_36787 (CHEMBL650308) Compound was tested for inhibition against Angiotensin II receptor, type 1 ChEMBL_36922 (CHEMBL647121) Inhibition constant against Angiotensin II receptor, type 1 was determined ChEMBL_36937 (CHEMBL650272) Inhibitory activity against Angiotensin II receptor, type 1 binding ChEMBL_34820 (CHEMBL648754) In vitro antagonistic activity by displacement of [125I]-Sar1-Ile8-A II at the rabbit aorta Angiotensin II receptor, type 1 ChEMBL_34830 (CHEMBL648764) In vitro binding affinity at Angiotensin II receptor, type 1 from rat liver membrane by [125I]- A II displacement. ChEMBL_35278 (CHEMBL648317) Binding affinity at Angiotensin II receptor, type 2 in pig uterus myometrial membranes by [125I]-Ang II displacement. ChEMBL_35435 (CHEMBL643795) Compound was tested for the inhibition of angiotensin II AT2 receptor by displacement of [125I]- Ang II to rat adrenal cortical microsomes ChEMBL_36495 (CHEMBL652312) Concentration required to 50% inhibition in specific binding of [125- I]A-II to Angiotensin II receptor in rat uterine membrane ChEMBL_757048 (CHEMBL1803889) Displacement of [125I]Tyr4-Sar1,Ile8-Angiotensin II from human Angiotensin 1 receptor after 60 mins by scintillation counting ChEBML_36482 Binding affinity against angiotensin II receptor in rat smooth muscle cell preparations ChEBML_36931 Binding affinity against Angiotensin II type 1 Receptor in rabbit aortic tissue ChEMBL_34646 (CHEMBL647291) Inhibitory activity against Angiotensin II receptor, type 1 in rabbit aorta ChEMBL_34650 (CHEMBL649709) Inhibitory activity was evaluated against angiotensin II type 1 rabbit aorta ChEMBL_34651 (CHEMBL649710) Inhibition of Angiotensin II receptor type 1 in rabbit aorta binding assay ChEMBL_34812 (CHEMBL648956) Compound was evaluated for the inhibition of Angiotensin II receptor induced vasoconstriction of the rabbit aorta ChEMBL_34962 (CHEMBL647884) In vitro binding affinity to the angiotensin II receptor, type 1 in rat liver ChEMBL_35257 (CHEMBL648563) Tested for Angiotensin II receptor, type 1 affinity in the presence of 0.25% BSA ChEMBL_35279 (CHEMBL647843) In vitro binding affinity at angiotensin II (type 2) receptor in rabbit uterus. ChEMBL_35565 (CHEMBL647513) In vitro binding affinity of compound was measured against angiotensin II (AT2) receptor ChEMBL_36159 (CHEMBL646971) Inhibition of [125I]AII binding to angiotensin II receptor of bovine adrenal cortex ChEMBL_36318 (CHEMBL652267) In vitro binding affinity against Angiotensin II receptor in rabbit aorta rings ChEMBL_36328 (CHEMBL650155) Compound was tested for inhibition of Angiotensin II receptor in rabbit aorta binding assay ChEMBL_36337 (CHEMBL650164) Binding affinity against Angiotensin II receptor, from rat adrenal gland ChEMBL_36342 (CHEMBL651149) Inhibition of [125I]-AII binding to Angiotensin II receptor of rat uterine membrane ChEMBL_36345 (CHEMBL651152) In vitro Angiotensin II receptor antagonist activity in rat adrenal cortex tissue. ChEMBL_36463 (CHEMBL653116) Tested for in vitro binding affinity against angiotensin II receptor of rat liver ChEMBL_36471 (CHEMBL653124) Inhibition of [125I]- AII binding to rat uterine membrane angiotensin II receptor ChEMBL_36623 (CHEMBL652863) Tested for binding affinity against angiotensin II receptor in rat adrenal cortex ChEMBL_36795 (CHEMBL650315) Inhibition against human angiotensin II receptor, type 1 (AG2-R) ChEMBL_34943 (CHEMBL647786) In vitro binding affinity at rat liver Angiotensin II receptor, type 1 was determined based on displacement of [125I]-Ang II ChEMBL_36488 (CHEMBL651556) Concentration required to 50% inhibition in specific binding of [125- I]A-II to Angiotensin II receptor from rat uterine membrane ChEBML_36774 Concentration that gives 50% inhibition for binding of 125-I-[Sar1, IIe8] angiotensin to Angiotensin II receptor, type 1 in bovine adrenal cortex membrane. ChEMBL_34821 (CHEMBL648755) In vitro antagonistic activity by displacement of [125I]-Sar1-Ile8-A II at the rat adrenal cortical aorta Angiotensin II receptor, type 1 ChEMBL_34951 (CHEMBL647794) Compound was evaluated for the in vitro inhibition of specific binding of [125I]-A II to Angiotensin II receptor, type 1 from rat adrenal membranes. ChEMBL_34976 (CHEMBL649504) Inhibitory concentration against specific binding of [125 I]Ang II to rat uterine membranes (Angiotensin II receptor, type 1) ChEMBL_35101 (CHEMBL649304) Inhibitory concentration against specific binding of [125 I]Ang II to rat uterine membranes (Angiotensin II receptor, type 1) ChEMBL_35423 (CHEMBL643597) The compound was tested for the ability to displace 50% of totally specifically bound [125I]- Ang II from Angiotensin II receptor, type 2 ChEMBL_34965 (CHEMBL647887) Inhibition of binding of [125I]- Sar,Ileu-angiotensin to Angiotensin II receptor, type 1 in the radioligand binding assay using rat liver membrane preparations ChEBML_34645 In vivo inhibitory concentration against Angiotensin II receptor, type 1 of rabbit aorta membrane ChEBML_34804 Binding affinity against angiotensin II receptor type 1 (AT1) from rat liver. ChEBML_35288 Compound was evaluated for inhibition of Angiotensin II receptor, type 2 in rat midbrain AT2 assay ChEBML_35414 Displacement of [1251][Sar1,IIe8]AII from rat midbrain angiotensin II (AT2) receptor ChEBML_36170 Inhibition of specific binding of [125 I ] Angiotensin-II (0.2 nM) to bovine adrenal cortex ChEBML_36178 Compound was tested in vitro for inhibitory activity against human Angiotensin II receptor in cultured preadipocytes ChEBML_36783 In vitro inhibition of the specific binding of [125I]angiotensin II to a guinea pig adrenal membrane preparation ChEBML_36794 In vivo inhibitory concentration against Angiotensin II receptor, type 1 of rat adrenal membrane ChEMBL_34649 (CHEMBL649708) Inhibitory activity was evaluated against Angiotensin II receptor, type 1 in rabbit aorta ChEMBL_34657 (CHEMBL649716) Binding affinity was evaluated towards Angiotensin II receptor, type 1 in rabbit aorta ChEMBL_34659 (CHEMBL649718) Inhibitory activity against Angiotensin II receptor, type 1 in rat adrenal membrane ChEMBL_35420 (CHEMBL643594) In vitro binding affinity of compound was measured against Angiotensin II receptor, type 2 ChEMBL_35559 (CHEMBL647339) In vivo inhibitory concentration against Angiotensin II, type 2 of rat midbrain membrane ChEMBL_36155 (CHEMBL648342) Binding affinity against angiotensin II receptor from rat liver; n=8 ChEMBL_36339 (CHEMBL650166) Binding affinity expressed as inhibitory concentration against angiotensin II of rat adrenal cortex ChEMBL_36341 (CHEMBL650168) Displacement of [3H]-AII from the Angiotensin II receptor isolated from the liver of rats ChEMBL_36481 (CHEMBL651550) Binding affinity against Angiotensin II receptor in rat smooth muscle cell preparations ChEMBL_36786 (CHEMBL650307) Compound was evaluated for inhibitory activity against human Angiotensin II receptor, type 1 ChEMBL_36932 (CHEMBL652727) Binding affinity to Angiotensin II receptor, type 1 in rabbit aorta binding assay ChEMBL_34953 (CHEMBL647796) Compound was evaluated in a radioligand binding assay to displace [125I]-Ang II from Angiotensin II receptor, type 1 in rat liver membranes ChEMBL_35262 (CHEMBL648568) The compound was tested for the ability to displace 50% of totally specifically bound [125I]- Ang II from Angiotensin II receptor, type 1 site ChEMBL_35275 (CHEMBL648580) Binding affinity towards Angiotensin II receptor, type 2 was measured through displacement of [125I]-Ang II in pig uterus myometrial membranes ChEBML_34644 Displacement of [1251][Sar1,IIe8]AII from rabbit aorta Angiotensin II receptor, type 1 ChEBML_35286 Binding affinity towards Angiotensin II receptor, type 2 in rat isolated adrenal medullary microsomes ChEBML_36161 Binding affinity expressed as inhibitory concentration towards bovine adrenal cortex angiotensin II receptor was measured ChEBML_36172 Concentration required for 50% inhibition of binding against Angiotensin II receptor in the bovine adrenal cortex tissue ChEBML_36494 In vitro inhibition of [125I]AII specific binding towards angiotensin II receptor in rat mesenteric membranes. ChEMBL_162637 (CHEMBL772135) Inhibitory concentration against [125I]angiotensin II(AII) induced contraction in rabbit aorta by 50% ChEMBL_2335695 Displacement of ([125I]-Tyr4)-Angiotensin-II from recombinant human AT2R by gamma scintillation counter assay ChEMBL_34827 (CHEMBL648761) Inhibition of [125I]AII binding to Angiotensin II receptor, type 1 of rat mesenteric arteries ChEMBL_34836 (CHEMBL648770) Compound was evaluated for its binding affinity towards rat Angiotensin II receptor, type 1 ChEMBL_34961 (CHEMBL647803) In vitro binding affinity to angiotensin II receptor, type 1 in rat adrenal cortex preparation ChEMBL_34964 (CHEMBL647886) In vivo inhibitory concentration against Angiotensin II receptor, type 1 of rat adrenal membrane ChEMBL_35256 (CHEMBL648562) Tested for Angiotensin II receptor, type 1 affinity in the absence of bovine serum albumin (BSA) ChEMBL_35260 (CHEMBL648566) Tested for inhibition of Angiotensin II receptor, type 1 in the absence of bovine serum albumin (BSA) ChEMBL_35288 (CHEMBL647852) Compound was evaluated for inhibition of Angiotensin II receptor, type 2 in rat midbrain AT2 assay ChEMBL_35431 (CHEMBL643791) Inhibitory activity against angiotensin II type 2 (AT2) receptor in rabbit uterine membranes. ChEMBL_35561 (CHEMBL645746) In vitro for binding affinity against angiotensin II receptor type 2 in rat midbrain membrane ChEMBL_36340 (CHEMBL650167) Binding affinity expressed as inhibitory concentration against angiotensin II receptor of rat adrenal cortex ChEMBL_36467 (CHEMBL653120) Ability to displace [125I]-labeled angiotensin II from its receptor of a rat uterus membrane ChEMBL_36478 (CHEMBL651547) Tested for inhibition of radioligand [Sar1,Ile5,8]AII binding to angiotensin II receptor in rat brain ChEMBL_36479 (CHEMBL651548) Tested for inhibition of radioligand [Sar1,Ile5,8]AII binding to angiotensin II receptor in rat uterus ChEMBL_36638 (CHEMBL652349) Inhibition of [125-I]-labeled angiotensin II binding to AT1 receptor in rat uterine membranes ChEMBL_36643 (CHEMBL652353) Displacement of [125I]-Sar1-Ile8-A II from rat adrenal Angiotensin-1 (AT-1) receptor ChEMBL_36769 (CHEMBL650292) Binding affinity against angiotensin II receptor type 2 (AT2) of rat adrenal medulla. ChEMBL_36776 (CHEMBL650298) In vitro antagonistic potency against Angiotensin II receptor, type 1 in rat adrenal cortex ChEMBL_36777 (CHEMBL883280) Inhibitory activity was evaluated against Angiotensin II receptor, type 1 in bovine adrenal membrane ChEMBL_36793 (CHEMBL875934) In vivo inhibitory concentration against Angiotensin II receptor, type 1 of human adrenal membrane ChEMBL_36920 (CHEMBL647120) Compound was evaluated for its binding affinity towards human Angiotensin II receptor, type 1 ChEBML_34806 Binding affinity for Angiotensin II receptor, type 1 measured by ability to displace [125I]- A II from its specific binding site in rat liver membrane ChEBML_35285 Binding affinity against Angiotensin II receptor type 2 from rat mid brain using [125I]-Sar1-Ile8-Ang II without BSA ChEMBL_35276 (CHEMBL648581) Inhibitory concentration against towards Angiotensin II receptor, type 2 was measured through displacement of [125I]-Ang II in pig uterus myometrial membranes ChEBML_34652 Tested in vitro for Angiotensin II receptor, type 1 binding affinity using rabbit aorta binding assay ChEBML_35270 Compound was evaluated for binding affinity against Angiotensin II receptor, type 1 using radioligand binding assay ChEBML_35281 Tested in vitro for Angiotensin II receptor, type 2 binding affinity using rabbit aorta binding assay ChEBML_35425 Compound was evaluated for binding affinity against Angiotensin II receptor, type 2 using radioligand binding assay ChEBML_35430 In vitro binding affinity at Angiotensin II Type 2 receptor in rabbit uterus membrane by [125I]AII displacement. ChEBML_36160 Ability to displace [125I]- labelled [Sar1,Ileu8] from angiotensin II receptor of bovine adrenal cortex membranes ChEBML_36772 Inhibition of [125I][Ile5]-AII binding to bovine adrenal cortex membrane Angiotensin II receptor type 1 ChEMBL_34653 (CHEMBL649712) Tested in vitro for binding affinity against Angiotensin II receptor, type 1 in rabbit aortic membrane ChEMBL_34809 (CHEMBL644585) Binding affinity towards Angiotensin II receptor, type 1 in rat isolated adrenal cortical microsomes ChEMBL_34948 (CHEMBL647791) Specific binding inhibition of [125I]AII to Angiotensin II receptor, type 1 in rat liver membrane ChEMBL_34954 (CHEMBL647797) In vitro inhibitory activity against rat Angiotensin II receptor, type 1 expressed in CHO cells ChEMBL_35113 (CHEMBL649315) In vitro binding affinity against Angiotensin II receptor, type 1 from rat liver membranes ChEMBL_35258 (CHEMBL648564) Tested for Angiotensin II receptor, type 1 affinity in the presence of 0.25% bovine serum albumin (BSA) ChEMBL_35272 (CHEMBL648577) Binding affinity towards Angiotensin II type 2 receptor in bovine cerebellar cortical membranes; Inactive ChEMBL_35273 (CHEMBL648578) In vitro inhibitory activity against Angiotensin II receptor type 2 in human adrenal membrane preparations. ChEMBL_35286 (CHEMBL647850) Binding affinity towards Angiotensin II receptor, type 2 in rat isolated adrenal medullary microsomes ChEMBL_35412 (CHEMBL643586) In vitro inhibitory activity against angiotensin II type 2 receptor in rat adrenal membrane preparations. ChEMBL_35413 (CHEMBL643587) In vitro inhibitory activity against Angiotensin II receptor, type 2 in rat midbrain membrane preparations. ChEMBL_36161 (CHEMBL646973) Binding affinity expressed as inhibitory concentration towards bovine adrenal cortex angiotensin II receptor was measured ChEMBL_36167 (CHEMBL646979) Concentration required for 50% inhibition of binding against Angiotensin II receptor in the bovine adrenal cortex tissue ChEMBL_36343 (CHEMBL651150) Concentration required for 50% inhibition of binding against Angiotensin II receptor in the rat adrenal cortex tissue ChEMBL_36344 (CHEMBL651151) Concentration required for 50% inhibition of binding against Angiotensin II receptor in the rat adrenal cortex tissue ChEMBL_36470 (CHEMBL653123) Competitive inhibition of Angiotensin II receptor binding of radiolabeled AII to rat adrenal glomerulosa tissue by 50% ChEMBL_36494 (CHEMBL652311) In vitro inhibition of [125I]-AII specific binding towards angiotensin II receptor in rat mesenteric membranes. ChEMBL_36648 (CHEMBL652358) In vitro binding affinity determined against angiotensin II AT1 receptor in rat adrenal cortex preparation ChEMBL_36782 (CHEMBL650303) In vitro antagonistic potency against Angiotensin II receptor, type 1 in guinea pig adrenal membrane ChEMBL_36791 (CHEMBL650312) In vitro inhibitory activity against angiotensin II receptor type 1, in human adrenal membrane preparations. ChEMBL_36949 (CHEMBL648852) Displacement of 125I[Sar,Ile] from rabbit aorta membrane Angiotensin II receptor type 1 ChEMBL_36952 (CHEMBL648855) In vitro inhibitory activity against Angiotensin II receptor, type 1 in rabbit aorta membrane preparations. ChEMBL_34974 (CHEMBL649503) Inhibitory concentration against [125 I]Ang II binding to rat pituitary membranes Angiotensin II receptor type 1 without 0.2% bovine serum albumin ChEBML_35407 In vitro binding affinity of compound was determined against Angiotensin II receptor, type 2 in rat adrenal medulla preparation ChEBML_36180 The compound was tested for its ability to displace [3H]Angiotensin II (300 ng/mL) from rabbit adrenal cortex ChEBML_36934 Compound was evaluated for inhibition of 125I[Sar1,Ile8] all binding to rabbit aorta Angiotensin II receptor, type 1 ChEMBL_2234597 (CHEMBL5148369) Displacement of [125-I]-[Sar1, Ile8]-angiotensin II from AT1R (unknown origin) by radioligand binding assay ChEMBL_2234598 (CHEMBL5148370) Displacement of [125-I]-[Sar1, Ile8]-angiotensin II from AT2R (unknown origin) by radioligand binding assay ChEMBL_34647 (CHEMBL648938) Inhibitory activity against Angiotensin II receptor, type 1 induced contractions in isolated rabbit aortic rings ChEMBL_34673 (CHEMBL645254) pA2 value determined in vitro against angiotensin II receptor, type 1 using rabbit aortic rings ChEMBL_34959 (CHEMBL647801) In vitro binding affinity at Angiotensin II Type 1 receptor in rat liver membrane by [125I]AII displacement. ChEMBL_36487 (CHEMBL856951) Inhibition of binding of [125I]All at the angiotensin II type 1 receptor (AT1 receptor) in rat liver membranes ChEMBL_36775 (CHEMBL650297) Concentration required for 50% inhibition of binding against Angiotensin II receptor, type 1 in bovine adrenal cortex ChEMBL_36779 (CHEMBL650300) Dissociation constant for [125 I] Ang binding to type 1 Angiotensin II receptor of bovine adrenocortical membranes ChEMBL_36938 (CHEMBL650273) Displacement of [125 I]Sar1Ile8-AII from type 1 Angiotensin II receptor of rabbit aorta membrane ChEMBL_34975 (CHEMBL884036) Inhibitory concentration against specific binding of [125 I]Ang II to rat pituitary membranes (Angiotensin II receptor, type 1) in presence of 0.2% bovine serum albumin ChEBML_34815 Concentration required to inhibit binding of radioligand [125I]AII to Angiotensin II receptor, type 1 in rat adrenal glomerulosa tissue ChEMBL_216862 (CHEMBL816861) In vitro inhibition of the c-src tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate ChEMBL_226175 (CHEMBL847372) In vitro inhibition of the v-abl tyrosine kinase activity in A431 membranes using angiotensin II as phosphate acceptor as substrate ChEMBL_29023 (CHEMBL646028) Binding affinity towards angiotensin II AT2 receptor subtype was determined using rat isolated adrenal cortical microsomes ChEMBL_34825 (CHEMBL648759) In vitro inhibition of specific binding of [125I]AII to Angiotensin II receptor, type 1 from rat liver membrane ChEMBL_35407 (CHEMBL647506) In vitro binding affinity of compound was determined against Angiotensin II receptor, type 2 in rat adrenal medulla preparation ChEMBL_35440 (CHEMBL643800) In vitro inhibitory activity against angiotensin II (AT2) receptor to displace 125I-Sar,Ile8-AII in rat midbrain ChEMBL_36168 (CHEMBL646980) Concentration required to inhibit [125I]AII binding to Angiotensin II receptor from membrane fractions of bovine adrenal cortex ChEMBL_36475 (CHEMBL653127) Inhibitory concentration that gave 50 percent displacement of specific binding of [3H]AII (2 nM) to Angiotensin II receptor ChEMBL_36477 (CHEMBL651546) Tested for binding affinity by measuring displacement of [125I]-Sar1 Ile8 angiotensin II from rat adrenal cortical membranes ChEMBL_36926 (CHEMBL652721) Displacement of [125I]Sar1-Ile8-AII (without BSA) from type 1 Angiotensin II receptor of rabbit aorta ChEBML_35107 Binding affinity of compound in presence of bovine serum albumin (BSA) at 0.01% against rat adrenal Angiotensin II receptor, type 1 ChEBML_35109 Binding affinity of compound in presence of bovine serum albumin (BSA) at 0.22% against rat adrenal Angiotensin II receptor, type 1 ChEBML_35287 Compound was evaluated for inhibition of 125I[Sar1,Ile8] aII binding to rat midbrain membrane preparation Angiotensin II receptor, type 2 ChEMBL_1461998 (CHEMBL3396448) Displacement of [125I]-[Sar1,Leu8]angiotensin II from human AT1 receptor expressed in african green monkey COS7 cells ChEMBL_34807 (CHEMBL644583) Binding affinity against Angiotensin II receptor, type 1 using [125I]Sar-Ile8-AII in rat liver membranes ChEMBL_34815 (CHEMBL648959) Concentration required to inhibit binding of radioligand [125I]AII to Angiotensin II receptor, type 1 in rat adrenal glomerulosa tissue ChEMBL_35104 (CHEMBL649307) Binding affinity of compound in presence of bovine serum albumin (BSA) at 0% against rat Angiotensin II receptor, type 1 ChEMBL_35106 (CHEMBL649309) Binding affinity of compound in presence of bovine serum albumin (BSA) at 0.01% against rat Angiotensin II receptor, type 1 ChEMBL_35108 (CHEMBL876743) Binding affinity of compound in presence of bovine serum albumin (BSA) at 0.22% against rat Angiotensin II receptor, type 1 ChEMBL_35406 (CHEMBL647505) In vitro antagonist activity against angiotensin II receptor type 2 in rat midbrain using [125I]-Sar,Ile AII. ChEMBL_36630 (CHEMBL652869) In vitro inhibitory activity against angiotensin II rabbit aorta AT1 receptor using radioligand [125I]-Sar Ile-AII ChEMBL_36763 (CHEMBL651250) In vitro inhibitory activity against angiotensin II rat midbrain AT2 receptor using radioligand [125I]-Sar Ile-AII ChEMBL_36797 (CHEMBL650317) Ability to displace [125I]AII binding to COS cells transfected with a cDNA encoding human Angiotensin II receptor, type 1 ChEMBL_36921 (CHEMBL876759) In vitro binding affinity towards Angiotensin II receptor, type 1 of human hepatoma cell line PLC-PRF-5 ChEMBL_36939 (CHEMBL650274) In vitro antagonist activity against angiotensin II receptor type 1 in rabbit aorta using [125I]-Sar, Ile AII. ChEMBL_36940 (CHEMBL648843) In vitro antagonist activity against angiotensin II receptor type 1 in rabbit aorta using [125I]-Sar, Ile AII. ChEMBL_36953 (CHEMBL648856) In vitro inhibitory activity against Angiotensin II receptor, type 1 to displace 125I-Sar,Ile8-AII in rabbit aorta ChEMBL_321028 (CHEMBL883660) Binding affinity for angiotensin II receptor, type 1 in rat liver membrane using [125I]-Ang II as radioligand, in pH 7.4 Tris-HCl buffer for 2 hr at 25 degree C ChEMBL_321033 (CHEMBL883665) Binding affinity for angiotensin II receptor, type 2 in pig uterus myometrium using [125I]-Ang II as radioligand, in pH 7.4 Tris-HCl buffer for 1.5 hr at 25 degree C ChEBML_36162 Displacement of [125 I]-AII (0.2 nM) from bovine adrenal cortical membrane angiotensin II (AII) receptor at 10e-7 M ChEMBL_34808 (CHEMBL644584) Binding affinity to Angiotensin II receptor, type 1 as displacement of 125I-Sar, Ile-AII from rat adrenal cortex membranes ChEMBL_34828 (CHEMBL648762) Inhibitory concentration that gives 50% displacement of specific binding at labeled angiotensin II type 1 receptor in rat adrenal cortical membranes. ChEMBL_35105 (CHEMBL649308) Binding affinity of compound in presence of bovine serum albumin (BSA) at 0% against rat adrenal Angiotensin II receptor, type 1 ChEMBL_35107 (CHEMBL649310) Binding affinity of compound in presence of bovine serum albumin (BSA) at 0.01% against rat adrenal Angiotensin II receptor, type 1 ChEMBL_35109 (CHEMBL649311) Binding affinity of compound in presence of bovine serum albumin (BSA) at 0.22% against rat adrenal Angiotensin II receptor, type 1 ChEMBL_35127 (CHEMBL648490) The compound was evaluated for the inhibition of [125I]-Sar-AII binding to Angiotensin II receptor, type 1 from purified rat liver membranes. ChEMBL_35291 (CHEMBL647855) In vitro antagonist activity against angiotensin II type 2 (AT2) receptor in rat midbrain using [125I]- Sar, Ile AII. ChEMBL_36946 (CHEMBL648849) Displacement of the specific binding ligand [125I]Sar1,Ile8-AII from Angiotensin II receptor, type 1 in rabbit aorta membrane. ChEMBL_2260014 (CHEMBL5215025) Inhibition of Angiotensin 2 binding to Angiotensin 2 receptor (unknown origin) ChEMBL_34822 (CHEMBL648756) In vitro binding affinity towards Angiotensin II receptor, type 1 to displace 125I[Sar,Ile] from rat adrenal tissue preparation ChEMBL_34824 (CHEMBL648758) In vitro binding affinity towards Angiotensin II receptor, type 1 to displace 125I[Sar,Ile] from rat brain tissue preparation ChEMBL_34945 (CHEMBL647788) Receptor binding affinity determined from competitive binding assay using 1251 labelled [Sar1,Ile8] angiotensin II in rat adrenocortical membranes ChEMBL_34952 (CHEMBL647795) Compound was evaluated in a binding assay using Chinese hamster ovary (CHO) cells stably expressing the rat Angiotensin II receptor, type 1 ChEMBL_35282 (CHEMBL647846) The compound was tested for binding affinity against Angiotensin II receptor, type 2 from rabbit uterus membrane by using [125I]AngII as radioligand ChEMBL_35409 (CHEMBL647508) In vitro binding affinity towards Angiotensin II receptor, type 2 to displace 125I[Sar,Ile] from rat adrenal tissue preparation ChEMBL_35411 (CHEMBL643585) In vitro binding affinity towards Angiotensin II receptor, type 2 to displace 125I[Sar,Ile] from rat brain tissue preparation ChEMBL_2234591 (CHEMBL5148363) Displacement of [125-I]-[Sar1Ile8]-angiotensin II from human AT1R expressed in HEK293 cell membrane assessed as inhibition constant by radioligand binding assay ChEMBL_2234592 (CHEMBL5148364) Displacement of [125-I]-[Sar1Ile8]-angiotensin II from human AT2R expressed in HEK293 cell membrane assessed as inhibition constant by radioligand binding assay ChEMBL_717424 (CHEMBL1670323) Displacement of radiolabeled angiotensin 2 from angiotensin AT1 receptor in bovine adrenal cortex membranes ChEMBL_717444 (CHEMBL1670343) Displacement of [3H]-angiotensin 2 from angiotensin AT1 receptor in human PLC-PRF5 cells ChEMBL_717449 (CHEMBL1670348) Displacement of [125I]-Sar1Ile8-angiotensin 2 from angiotensin AT1 receptor in rabbit aortic membranes ChEMBL_717461 (CHEMBL1670666) Displacement of [125I]-angiotensin 2 from angiotensin AT1 receptor in bovine adrenal cortical membranes Binding Assay The binding assay was performed using 22.5 pM [125I]-angiotensin II [manufactured by PerkinElmer, USA] (9 μg) in the presence of AT1 membrane and test compound. ChEMBL_35274 (CHEMBL648579) In vitro inhibitory activity against Angiotensin II receptor, type 2 in human adrenal membrane preparations. For this assay, only 0.02%BSA was present in the assay mixture. ChEMBL_36792 (CHEMBL650313) In vitro inhibitory activity against Angiotensin II receptor, type 1 in human adrenal membrane preparations. For this assay, only 0.02%BSA was present in the assay mixture. ChEMBL_901964 (CHEMBL3052128) Displacement of [125I]-angiotensin 2 from angiotensin AT1 receptor in Rattus norvegicus (rat) uterine membranes ChEBML_36928 Ability to displace [125I]Sar1-Ile8-AII from angiotensin II receptor, type 1 in rabbit aorta in presence of 0.2% bovine serum albumin (BSA) was determined in vitro ChEBML_36947 Binding affinity evaluated by its ability to displace the specific binding ligand 125I-SAR1, Ile8-AII from Angiotensin II receptor, type 1 in rabbit aorta membrane ChEMBL_1566203 (CHEMBL3788344) Displacement of [125I]-Ang II from Angiotensin 2 type-1A receptor in rat vascular smooth muscle cells after 150 mins by gamma counting method ChEMBL_1922000 (CHEMBL4424845) Inhibition of human N-terminal GST-tagged EGFR (696 to end residues) expressed in baculovirus infected Sf21 insect cells using Angiotensin II peptide as substrate ChEBML_164871 In vitro inhibition of angiotensin converting enzyme ChEBML_34781 Inhibition of Angiotensin I converting enzyme ChEBML_34917 Inhibition of Angiotensin I converting enzyme ChEBML_35586 Inhibitory constant angiotensin converting enzyme ChEBML_36748 Inhibition of Angiotensin I converting enzyme ChEMBL_2273371 Inhibition of angiotensin 2 (unknown origin) ChEMBL_830165 (CHEMBL2061975) Inhibition of angiotensin AT1 receptor ChEMBL_717412 (CHEMBL1670311) Antagonist activity at angiotensin AT1 receptor in rabbit aorta assessed as reduction of angiotensin 2-induced contractile response ChEBML_35408 In vitro binding affinity towards Angiotensin II receptor, type 2 determined as its ability to displace 125I-Sarl,Ile8-AII from the receptor expressed in rat midbrain membrane. ChEBML_36944 In vitro antagonistic activity for angiotensin II receptor, type 1 by displacing 125I[Sar, ILe8 ]AII radioligand in rabbit aorta membrane without using bovine serum albumin (BSA) ChEMBL_36654 (CHEMBL649914) In vitro binding affinity against angiotensin II (AT2) receptor to competitively block the specific binding of [125I]- [Sar1,Ile8] AII to a rat mid brain AT2 receptor preparation ChEMBL_36767 (CHEMBL651097) In vitro binding affinity against angiotensin II (AT2) receptor to competitively block the specific binding of [125I]- [Sar1,Ile8] AII to a rat mid brain AT2 receptor preparation ChEMBL_36927 (CHEMBL652722) Ability to displace [125I]Sar1-Ile8-AII from Angiotensin II receptor, type 1 in rabbit aorta in presence of 0.2% bovine serum albumin (BSA) was determined in vitro ChEMBL_36928 (CHEMBL652723) Ability to displace [125I]Sar1-Ile8-AII from angiotensin II receptor, type 1 in rabbit aorta in presence of 0.2% bovine serum albumin (BSA) was determined in vitro ChEMBL_717451 (CHEMBL1670350) Antagonist activity at angiotensin AT1 receptor in rabbit aortic strip assessed as inhibition of angiotensin 2-induced contractile response ChEMBL_717452 (CHEMBL1670351) Antagonist activity at angiotensin AT1 receptor in rabbit adrenal cortex assessed as inhibition of angiotensin 2-induced contractile response ChEBML_36950 In vitro binding affinity towards Angiotensin II type 1-AT1 receptor determined as its ability to displace 125I-Sarl,Ile8-AII from the receptor expressed in rabbit aorta membrane. ChEMBL_2129826 (CHEMBL4839255) Antagonist activity at human AT1 overexpressed in CHO-K1 cells in presence of 10 nM [Val5-angiotensin II measured after 90 mins by HTRF based IP-one assay ChEMBL_36944 (CHEMBL648847) In vitro antagonistic activity for angiotensin II receptor, type 1 by displacing 125I[Sar, ILe8 ]AII radioligand in rabbit aorta membrane without using bovine serum albumin (BSA) ChEMBL_36945 (CHEMBL648848) In vitro binding affinity determined by its ability to displace the specific binding ligand [125I]-Sar1, Ile8-AII from Angiotensin II receptor, type 1 in rabbit aorta membranes ChEMBL_36948 (CHEMBL648851) In vitro binding affinity evaluated by its ability to displace the specific binding ligand 125I-SAR1, Ile8-AII from Angiotensin II receptor, type 1 in rabbit aorta membrane ChEBML_45239 Inhibition of human carbonic anhydrase II (hCA II) ChEBML_88592 Inhibition of Inosine Monophosphate Dehydrogenase II (IMPDH II) ChEMBL_53368 (CHEMBL666614) Inhibition of human Dipeptidylpeptidase II (DPP II) ChEBML_34789 In vitro inhibition of Angiotensin I converting enzyme ChEBML_34929 Inhibitory activity against angiotensin converting enzyme ChEBML_35221 Inhibition of Angiotensin I converting enzyme in rat ChEBML_35382 In vitro inhibition of Angiotensin I converting enzyme. ChEMBL_164871 (CHEMBL772279) In vitro inhibition of angiotensin converting enzyme ChEMBL_2297239 Inhibition of angiotensin-converting enzyme (unknown origin) ChEMBL_2297240 Inhibition of rabbit lung angiotensin-converting enzyme ChEMBL_2346148 Inhibition of angiotensin-converting enzyme (unknown origin) ChEMBL_34781 (CHEMBL646063) Inhibition of Angiotensin I converting enzyme ChEMBL_34917 (CHEMBL648453) Inhibition of Angiotensin I converting enzyme ChEMBL_35591 (CHEMBL648287) Inhibition of angiotensin converting enzyme (ACE) ChEMBL_35983 (CHEMBL645286) Inhibition of Angiotensin I converting enzyme ChEMBL_36009 (CHEMBL644716) Inhibition of Angiotensin I converting enzyme ChEMBL_717329 (CHEMBL1669998) Antagonist activity at angiotensin AT1 receptor ChEMBL_717437 (CHEMBL1670336) Binding affinity to angiotensin AT1 receptor ChEMBL_717466 (CHEMBL1670671) Binding affinity to angiotensin AT2 receptor ChEMBL_879301 (CHEMBL2208699) Antagonist activity at angiotensin 1 receptor ChEMBL_879302 (CHEMBL2208700) Antagonist activity at angiotensin 2 receptor ChEMBL_910709 (CHEMBL3056264) Displacement of [125I]angiotensin 2 from type-1 angiotensin 2 receptor in Bos taurus (bovine) adrenal cortical membrane ChEMBL_209910 (CHEMBL811914) Inhibition of Tau Protein Kinase II (TPK II) ChEMBL_802645 (CHEMBL1953053) Antagonist activity at angiotensin 2 receptor type 1 in New Zealand White rabbit descending thoracic aorta rings assessed as inhibition of angiotensin 2-induced contraction preincubated for 30 mins prior angiotensin 2 challenge ChEBML_35058 Ability to inhibit Angiotensin I converting enzyme was determined ChEBML_35076 Inhibitory activity against Angiotensin I converting enzyme ChEBML_35218 Inhibitory activity against Angiotensin I converting enzyme ChEBML_35571 Inhibitory concentration against angiotensin converting enzyme (ACE) ChEBML_35590 In vitro inhibition against angiotensin converting enzyme (ACE) ChEBML_36002 Binding affinity against Angiotensin I converting enzyme ChEBML_36003 Compound was evaluated for the inhibition of Angiotensin I converting enzyme ChEBML_36004 Compound was evaluated for the inhibition of Angiotensin I converting enzyme ChEBML_36007 Inhibitory activity against Angiotensin I converting enzyme ChEBML_36013 Compound was measured for the inhibition of Angiotensin I converting enzyme ChEBML_36017 Compound was measured for the inhibition of Angiotensin I converting enzyme ChEBML_36145 Inhibition constant determined for Angiotensin I converting enzyme ChEBML_36148 The compound was tested for inhibition of Angiotensin I converting enzyme ChEBML_36150 Inhibitory activity against angiotensin converting enzyme (ACE) ChEBML_36890 Inhibition of guinea pig angiotensin I converting enzyme ChEMBL_2207731 (CHEMBL5120439) Inhibition of angiotensin-converting enzyme (unknown origin) ChEMBL_2238210 (CHEMBL5152106) Inhibition of angiotensin converting enzyme (unknown origin) ChEMBL_34789 (CHEMBL643766) In vitro inhibition of Angiotensin I converting enzyme ChEMBL_35221 (CHEMBL648944) Inhibition of Angiotensin I converting enzyme in rat ChEMBL_35589 (CHEMBL885304) Inhibitory activity against angiotensin converting enzyme ChEMBL_35981 (CHEMBL646945) Inhibition of angiotensin I converting enzyme in silico ChEMBL_36897 (CHEMBL648687) Inhibition against angiotensin I converting enzyme ChEMBL_655602 (CHEMBL1244646) Binding affinity to angiotensin converting enzyme 2 ChEMBL_757051 (CHEMBL1803892) Binding affinity to human Angiotensin receptor 1 ChEMBL_757052 (CHEMBL1803893) Binding affinity to human Angiotensin receptor 2 ChEMBL_934611 (CHEMBL2317817) Inhibition of angiotensin converting enzyme (unknown origin) ChEMBL_987692 (CHEMBL2439560) Displacement of [125I]-Sar1Ile8-angiotensin 2 from angiotensin 2 AT2 receptor (unknown origin) after 180 mins by gamma counting analysis ChEMBL_987693 (CHEMBL2439561) Displacement of [125I]-Sar1Ile8-angiotensin 2 from angiotensin 2 AT1 receptor (unknown origin) after 180 mins by gamma counting analysis ChEBML_234 Inhibition of 5'-inosine monophosphate dehydrogenase type II (IMPDH II) ChEBML_45232 Inhibitory activity against human carbonic anhydrase II (hCA II) ChEMBL_53367 (CHEMBL666613) Inhibitory activity of compound against Dipeptidylpeptidase II (DPP II) ChEMBL_53369 (CHEMBL666615) Inhibitory activity of compound against Dipeptidylpeptidase II (DPP II) ChEMBL_53502 (CHEMBL666472) Inhibitory activity of compound against Dipeptidylpeptidase II (DPP II) ChEBML_45046 Inhibitory activity against human cloned carbonic anhydrase II (hCA II) ChEMBL_302394 (CHEMBL829640) Ki value against human carbonic anhydrase II (hCA II) ChEMBL_320718 (CHEMBL881704) Inhibitory activity against human Carbonic anhydrase II (hCA II) ChEMBL_45051 (CHEMBL658049) Dissociation constant against human Carbonic anhydrase II (HCA II) ChEMBL_45076 (CHEMBL657147) Inhibitory activity against human Carbonic anhydrase II (hCA II) ChEBML_34797 In vitro inhibitory activity against Angiotensin I converting enzyme ChEBML_34935 Tested for inhibitory constant against Angiotensin I converting enzyme ChEBML_35061 In vitro inhibition of Angiotensin I converting enzyme in rabbit lung ChEBML_35065 Tested for inhibition of Angiotensin I converting enzyme from rabbit. ChEBML_35222 In vitro inhibitory activity against Angiotensin I converting enzyme ChEBML_35985 Compound tested in vitro for inhibition of Angiotensin I converting enzyme ChEBML_35992 In vitro inhibitory activity against Angiotensin I converting enzyme ChEBML_35994 Inhibitory concentration (isomer A) against Angiotensin I converting enzyme ChEBML_36011 Compound tested in vitro for inhibition of Angiotensin I converting enzyme ChEBML_36014 In vitro inhibitory activity against Angiotensin I converting enzyme ChEBML_36327 Binding affinity towards Angiotensin receptor from rabbit aorta ChEMBL_1827405 (CHEMBL4327279) Antagonist activity at angiotensin-2 receptor (unknown origin) ChEMBL_320763 (CHEMBL884718) Inhibition constant against angiotensin I converting enzyme ChEMBL_321232 (CHEMBL881232) Inhibitory concentration against angiotensin I converting enzyme ChEMBL_34790 (CHEMBL643767) In vitro inhibition of angiotensin I converting enzyme (ACE) ChEMBL_34927 (CHEMBL647672) Binding affinity against Angiotensin I converting enzyme ChEMBL_35058 (CHEMBL648932) Ability to inhibit Angiotensin I converting enzyme was determined ChEMBL_35223 (CHEMBL648945) In vitro inhibition of rat angiotensin I converting enzyme ChEMBL_35230 (CHEMBL647399) Inhibitory activity against angiotensin I converting enzyme ChEMBL_35584 (CHEMBL648282) Tested in vitro for inhibition of Angiotensin converting enzyme (ACE) ChEMBL_35587 (CHEMBL648285) In vitro inhibition against angiotensin converting enzyme (ACE) ChEMBL_35588 (CHEMBL876577) In vitro inhibitory concentration against angiotensin-converting enzyme ChEMBL_35993 (CHEMBL644702) Inhibitory activity against Angiotensin I converting enzyme ChEMBL_36145 (CHEMBL648333) Inhibition constant determined for Angiotensin I converting enzyme ChEMBL_36150 (CHEMBL648337) Inhibitory activity against angiotensin converting enzyme (ACE) ChEMBL_36890 (CHEMBL648350) Inhibition of guinea pig angiotensin I converting enzyme ChEMBL_544516 (CHEMBL1013488) Inhibition of angiotensin-converting enzyme in whole blood by HPLC ChEMBL_6962 (CHEMBL618671) Inhibitory activity against angiotensin-converting enzyme (ACE). ChEMBL_717323 (CHEMBL1669992) Antagonist activity at angiotensin AT1 receptor in rabbit aorta ChEMBL_828626 (CHEMBL2060183) Antagonist activity at type 1 angiotensin 2 receptor ChEMBL_828628 (CHEMBL2060185) Binding affinity at type 1 angiotensin 2 receptor ChEMBL_510120 (CHEMBL998774) Antagonist activity at HA-tagged mouse AT1a angiotensin 2 receptor expressed in HEK293T cells assessed as decrease in angiotensin 2-induced intracellular calcium uptake
BDBM50139783 CHEMBL404996 Angiotensin II analogue
BDBM50139784 CHEMBL386257 Angiotensin II analogue
BDBM50139786 CHEMBL407801 Angiotensin II analogue
BDBM50228195 Angiotensin Ii CHEBI:2719
CHEMBL415394 BDBM50139788 Angiotensin II analogue
CHEMBL408403 5-L-isoleucineangiotensin II 5-isoleucine-angiotensin II angiotensin II (human) US9624243, Angiotensin II L-alpha-aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-L-phenylalanine Ile(5)-angiotensin II N-(1-(N-(N-(N-(N-(N(2)-L-alpha-aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine isoleucine(5)-angiotensin II BDBM50236697 angiotensin II (mouse) Asp-Arg-Val-Tyr-Ile-His-Pro-Phe Angiotensin II human angiotensin II
BDBM82077 Angiotensin II NSC_439662 CAS_11128-99-7
BDBM50112098 CHEMBL412045 analog of Angiotensin II with cis vinyl sulfide bridge
analog of Angiotensin II with trans vinyl sulfide bridge BDBM50112097 CHEMBL266450
BDBM50048128 Asp-Arg-Val-Tyr-Val-His-Pro-Phe (Angiotensin II) CHEMBL216830 AspArgValTyrValHisProPh [Asp1-Arg2-Val3-Tyr4-Val5-His6-Pro7-Phe8](angiotensin II)
ANGIOTENSIN AMIDE BDBM50228199 Angiotensinamide
BDBM50048127 Angiotensin III CHEMBL56448
CHEMBL3144487 Angiotensin I BDBM50048131
US10370388, Compound Angiotensin BDBM410295
BDBM50599316 APLYSINAMISINE II Aplysinamisine II
BDBM642187 US20240116898, No II US11845740, No II
US9464092, II BDBM253943 US9527857, II
US9695185, II US9260446, (II) BDBM206761
US10919901, Compound Formula II US10472367, Compound Formula II BDBM98028 US8487096, II US9221824, Formula II
BDBM270645 US10059705, II-40 US10059705, II-105 US10059705, II-104
US8895581, II-20 US8895581, II-10 US8895581, II-13 BDBM139789
US11136327, Example II-15 BDBM142928 US9802939, II-15 US8940720, II-15 US10487086, Example II-15
US9802939, II-10 BDBM142892 US11136327, Example II-10 US8940720, II-10 US10487086, Example II-10
US9802939, II-3 US11136327, Example II-3 US8940720, II-3 BDBM142890 US10487086, Example II-3
US9802939, II-4 US11136327, Example II-4 US8940720, II-4 BDBM142891 US10487086, Example II-4
US9802939, II-13 BDBM142927 US11136327, Example II-13 US8940720, II-13
US9802939, II-58 US8940720, II-58 BDBM142894 US10487086, Example II-58
BDBM209458 US11077107, Example II-2 US9266891, II-2 US10328074, Example II-2
BDBM209459 US11077107, Example II-3 US9266891, II-3 US10328074, Example II-3
US10328074, Example II-1 BDBM209457 US9266891, II-1 US11077107, Example II-1
US11136327, Example II-35 US8940720, II-35 US10487086, Example II-35 BDBM142930
US11136327, Example II-43 US8940720, II-43 US10487086, Example II-43 BDBM142893
US8940720, II-62 US10487086, Example II-62 BDBM142895 US11136327, Example II-62
US9273046, Intermediate II US10576087, Compound Intermediate II BDBM210056 US9895376, Compound Intermediate-II
BDBM111587 US8822457, II-1 US8618098, II-1
BDBM111588 US8822457, II-3 US8618098, II-3
BDBM122828 US8735386, II-3 US8735386, II-18
BDBM122829 US8735386, II-7 US8735386, II-13
BDBM158456 US9029399, 30A-II US9339501, 30A-II
BDBM206762 US9260446, (II-S) US9695185, II-S
BDBM270625 US10059705, II-21 US10059705, II-20
BDBM270662 US10059705, II-58 US10059705, II-57
BDBM270666 US10059705, II-61 US10059705, II-62
BDBM270669 US10059705, II-65 US10059705, II-64
BDBM270680 US10059705, II-76 US10059705, II-75
BDBM270682 US10059705, II-78 US10059705, II-77
BDBM270688 US10059705, II-83 US10059705, II-84
BDBM270690 US10059705, II-85 US10059705, II-86
BDBM270711 US10059705, II-107 US10059705, II-106
BDBM270713 US10059705, II-109 US10059705, II-108
BDBM270719 US10059705, II-115 US10059705, II-114
BDBM270722 US10059705, II-118 US10059705, II-117
BDBM270724 US10059705, II-120 US10059705, II-119
BDBM270746 US10059705, II-142 US10059705, II-141
BDBM270753 US10059705, II-149 US10059705, II-148
BDBM270755 US10059705, II-151 US10059705, II-150
BDBM270757 US10059705, II-153 US10059705, II-152
BDBM270763 US10059705, II-159 US10059705, II-158
BDBM270765 US10059705, II-161 US10059705, II-160
BDBM270767 US10059705, II-163 US10059705, II-162
BDBM270779 US10059705, II-175 US10059705, II-174
BDBM270788 US10059705, II-184 US10059705, II-183
BDBM270798 US10059705, II-194 US10059705, II-193
BDBM270800 US10059705, II-196 US10059705, II-195
BDBM270809 US10059705, II-205 US10059705, II-204
BDBM270811 US10059705, II-207 US10059705, II-206
BDBM270813 US10059705, II-209 US10059705, II-208
US10059705, II-100 BDBM270704 US10059705, II-99
US10059705, II-102 US10059705, II-101 BDBM270706
US10059705, II-111 US10059705, II-110 BDBM270715
US10059705, II-113 US10059705, II-112 BDBM270717
US10059705, II-122 US10059705, II-121 BDBM270726
US10059705, II-144 US10059705, II-143 BDBM270748
US10059705, II-146 US10059705, II-145 BDBM270750
US10059705, II-155 US10059705, II-154 BDBM270759
US10059705, II-179 US10059705, II-178 BDBM270783
US10059705, II-18 BDBM270623 US10059705, II-19
US10059705, II-182 US10059705, II-181 BDBM270786
US10059705, II-186 US10059705, II-185 BDBM270790
US10059705, II-188 US10059705, II-187 BDBM270792
US10059705, II-189 US10059705, II-190 BDBM270794
US10059705, II-192 US10059705, II-191 BDBM270796
US10059705, II-198 US10059705, II-197 BDBM270802
US10059705, II-200 US10059705, II-199 BDBM270804
US10059705, II-201 BDBM270806 US10059705, II-202
US10059705, II-59 US10059705, II-60 BDBM270664
US10059705, II-90 BDBM270694 US10059705, II-89
US10059705, II-92 US10059705, II-91 BDBM270696
US8735386, II-2 BDBM122827 US8735386, II-17
US9029399, 31A-II US9339501, 31A-II BDBM158458
US9029399, 32A-II BDBM158460 US9339501, 32A-II
US9187462, II-2 US9187462, II-1 BDBM192391
US20240174690, Example II-149 US20240174690, Example II-207 US20240174690, Example II-209 BDBM678305
BDBM172376 US9598411, Ref. No. B56c(ii) US9090618, B56c(ii)
BDBM172378 US9598411, Ref. No. E32c(ii) US9090618, E32c(ii)
BDBM172379 US9598411, Ref. No. E56c(ii) US9090618, E56c(ii)
US9090618, H30b(ii) BDBM172384 US9598411, Ref. No. H30b(ii)
US9090618, H32b(ii) BDBM172386 US9598411, Ref. No. H32b(ii)
US9598411, Ref. No. E30c(ii) BDBM172377 US9090618, E30c(ii)
US9598411, Ref. No. H30d(ii) US9090618, H30d(ii) BDBM172385
US9598411, Ref. No. H32d(ii) BDBM172387 US9090618, H32d(ii)
US9598411, Ref. No. H56b(ii) BDBM172390 US9090618, H56b(ii)
US9598411, Ref. No. H56d(ii) BDBM172391 US9090618, H56d(ii)
US9598411, Ref. No. H58d(ii) US9090618, H58d(ii) BDBM172392
US9598411, Ref. No. H62d(ii) US9090618, H62d(ii) BDBM172393
BDBM421750 US10508088, Example II-21 US10538496, Compound II-21
BDBM421751 US10538496, Compound II-22 US10508088, Example II-22
BDBM421759 US10508088, Example II-30 US10538496, Compound II-30
BDBM421760 US10508088, Example II-31 US10538496, Compound II-31
BDBM421761 US10508088, Example II-32 US10538496, Compound II-32
BDBM421762 US10538496, Compound II-33 US10508088, Example II-33
BDBM421770 US10508088, Example II-41 US10538496, Compound II-41
BDBM421771 US10508088, Example II-42 US10538496, Compound II-42
BDBM421772 US10508088, Example II-43 US10538496, Compound II-43
BDBM421773 US10538496, Compound II-44 US10508088, Example II-44
BDBM421780 US10508088, Example II-51 US10538496, Compound II-51
BDBM421781 US10508088, Example II-52 US10538496, Compound II-52
BDBM421782 US10508088, Example II-53 US10538496, Compound II-53
BDBM421783 US10508088, Example II-54 US10538496, Compound II-54
BDBM421784 US10538496, Compound II-55 US10508088, Example II-55
BDBM421795 US10538496, Compound II-66 US10508088, Example II-66
BDBM421805 US10508088, Example II-76 US10538496, Compound II-76
BDBM421814 US10508088, Example II-85 US10538496, Compound II-85
BDBM421816 US10508088, Example II-87 US10538496, Compound II-87
BDBM476859 US10870660, Compound II-005 US11345716, Compound II-005
BDBM476866 US11345716, Compound II-053 US10870660, Compound II-053
BDBM476869 US10870660, Compound II-077 US11345716, Compound II-077
BDBM476911 US10870660, Compound II-014 US11345716, Compound II-014
BDBM476920 US11345716, Compound II-070 US10870660, Compound II-070
BDBM476923 US11345716, Compound II-081 US10870660, Compound II-081
BDBM476926 US10870660, Compound II-088 US11345716, Compound II-088
BDBM678321 US20240174690, Example II-165 US20240174690, Example II-208
BDBM678344 US20240174690, Example II-198 US20240174690, Example II-193
PTP Inhibitor XXXI, II-B08 US9522881, II-B08 BDBM260053
US10376531, Compound II-b US10813942, Compound II-b BDBM408854
US10508088, Example II-16 US10538496, Compound II-16 BDBM421745
US10508088, Example II-17 US10538496, Compound II-17 BDBM421746
US10508088, Example II-18 US10538496, Compound II-18 BDBM421747
US10508088, Example II-19 BDBM421748 US10538496, Compound II-19
US10508088, Example II-20 BDBM421749 US10538496, Compound II-20
US10508088, Example II-27 US10538496, Compound II-27 BDBM421756
US10508088, Example II-28 US10538496, Compound II-28 BDBM421757
US10508088, Example II-29 US10538496, Compound II-29 BDBM421758
US10508088, Example II-39 US10538496, Compound II-39 BDBM421768
US10508088, Example II-40 BDBM421769 US10538496, Compound II-40
US10508088, Example II-49 US10538496, Compound II-49 BDBM421778
US10508088, Example II-50 US10538496, Compound II-50 BDBM421779
US10508088, Example II-75 BDBM421804 US10538496, Compound II-75
US10508088, Example II-81 US10538496, Compound II-81 BDBM421810
US10508088, Example II-83 US10538496, Compound II-83 BDBM421812
US10508088, Example II-84 BDBM421813 US10538496, Compound II-84
US10508088, Example II-86 BDBM421815 US10538496, Compound II-86
US10508088, Example II-90 US10538496, Compound II-90 BDBM421819
US10508088, Example II-91 US10538496, Compound II-91 BDBM421820
US10508088, Example II-92 US10538496, Compound II-92 BDBM421821
US10508088, Example II-93 US10538496, Compound II-93 BDBM421822
US10538496, Compound II-13 BDBM421742 US10508088, Example II-13
US10538496, Compound II-15 BDBM421744 US10508088, Example II-15
US10538496, Compound II-2 BDBM421731 US10508088, Example II-2
US10538496, Compound II-23 BDBM421752 US10508088, Example II-23
US10538496, Compound II-24 BDBM421753 US10508088, Example II-24
US10538496, Compound II-25 BDBM421754 US10508088, Example II-25
US10538496, Compound II-26 BDBM421755 US10508088, Example II-26
US10538496, Compound II-34 BDBM421763 US10508088, Example II-34
US10538496, Compound II-35 BDBM421764 US10508088, Example II-35
US10538496, Compound II-36 BDBM421765 US10508088, Example II-36
US10538496, Compound II-37 BDBM421766 US10508088, Example II-37
US10538496, Compound II-45 BDBM421774 US10508088, Example II-45
US10538496, Compound II-46 BDBM421775 US10508088, Example II-46
US10538496, Compound II-47 BDBM421776 US10508088, Example II-47
US10538496, Compound II-48 BDBM421777 US10508088, Example II-48
US10538496, Compound II-6 BDBM421735 US10508088, Example II-6
US10538496, Compound II-68 BDBM421797 US10508088, Example II-68
US10538496, Compound II-69 BDBM421798 US10508088, Example II-69
US10538496, Compound II-7 BDBM421736 US10508088, Example II-7
US10538496, Compound II-77 BDBM421806 US10508088, Example II-77
US10538496, Compound II-78 BDBM421807 US10508088, Example II-78
US10538496, Compound II-79 BDBM421808 US10508088, Example II-79
US10538496, Compound II-88 BDBM421817 US10508088, Example II-88
US10538496, Compound II-89 BDBM421818 US10508088, Example II-89
US10752613, Compound Formula (Ii) BDBM458106 US11161835, Compound Formula (Ii)
US10870660, Compound II-029 BDBM476862 US11345716, Compound II-029
US10870660, Compound II-046 US11345716, Compound II-087 BDBM476863
US10870660, Compound II-048 US11345716, Compound II-048 BDBM476916
US10870660, Compound II-090 BDBM476871 US11345716, Compound II-090
US10870660, Compound II-099 US11345716, Compound II-099 BDBM476872
US10870660, Compound II-105 BDBM476927 US11345716, Compound II-105
US11098061, Compound II-17 US11098061, Compound II-19 BDBM515405
US11198695, Example II-275 US11198695, Example II-276 BDBM529338
US11345716, Compound II-072 BDBM476921 US10870660, Compound II-072
US11345716, Compound II-078 BDBM476922 US10870660, Compound II-078
US11345716, Compound II-084 BDBM476924 US10870660, Compound II-084
US11345716, Compound II-085 US10870660, Compound II-085 BDBM476870
BDBM244800 US9447055, II
BDBM50413784 UROTENSIN-II
BDBM50432257 SIALOKININ II
BDBM50476407 dihydroisotanshinone ii
BDBM50476408 isotanshinone ii
BDBM50517314 Urotensin-II
BDBM82263 COMPOUND II
OLOMOUCINE II BDBM50366800
US8546451, II BDBM102984
US9034574, II BDBM158506
US9402878, II BDBM237161
BDBM183264 US9688643, II-009 US9718790, I-0441 US9150546, II-009
BDBM438108 US10730853, Compound XII US11420955, Compound II US10618886, Compound II
BDBM455304 US11352356, Table II.9 US10730874, Compound TABLE II.9
US9150546, II-002 BDBM183261 US9718790, I-0434 US9688643, II-002
US9150546, II-006 BDBM183262 US9688643, II-006 US9718790, I-0438
US9150546, II-010 BDBM183265 US9718790, I-0442 US9688643, II-010
US9150546, II-013 BDBM183392 US9718790, I-0577 US9688643, II-013
US9150546, II-015 US9718790, I-0579 US9688643, II-015 BDBM183394
US9688643, II-014 US9150546, II-014 BDBM183393 US9718790, I-0578
US9718790, I-0440 BDBM183263 US9688643, II-008 US9150546, II-008
US9718790, I-0576 US9150546, II-012 BDBM183391 US9688643, II-012
BDBM579372 US11479560, Title WZ-II-253 US11479560, Title WZ-II-252
US11479560, Title WZ-II-149 BDBM579354 US11479560, Title WZ-II-231
US11479560, Title WZ-II-187 US11479560, Title WZ-II-186 BDBM579360
US11479560, Title WZ-II-206 US11479560, Title WZ-II-205 BDBM579362
US11479560, Title WZ-II-270 BDBM579374 US11479560, Title WZ-II-269
US11866416, Compound SN-II-81F BDBM644013 US11866416, Compound SN-II-81Cl
BDBM102444 US8536166, II-11
BDBM102445 US8536166, II-12
BDBM105385 US8575203, II-1
BDBM105386 US8575203, II-2
BDBM105387 US8575203, II-3
BDBM105394 US8575203, II-10
BDBM105404 US8575203, II-20
BDBM105405 US8575203, II-21
BDBM105406 US8575203, II-22
BDBM105407 US8575203, II-23
BDBM105408 US8575203, II-24
BDBM105409 US8575203, II-25
BDBM105415 US8575203, II-31
BDBM105416 US8575203, II-32
BDBM105417 US8575203, II-33
BDBM105418 US8575203, II-34
BDBM105419 US8575203, II-35
BDBM105424 US8575203, II-40
BDBM105425 US8575203, II-41
BDBM105426 US8575203, II-42
BDBM105427 US8575203, II-43
BDBM105429 US8575203, II-45
BDBM105434 US8575203, II-50
BDBM105435 US8575203, II-51
BDBM105436 US8575203, II-52
BDBM105437 US8575203, II-53
BDBM105438 US8575203, II-54
BDBM105439 US8575203, II-55
BDBM105440 US8575203, II-56
BDBM105445 US8575203, II-61
BDBM105446 US8575203, II-62
BDBM105447 US8575203, II-63
BDBM105449 US8575203, II-65
BDBM105450 US8575203, II-66
BDBM105451 US8575203, II-67
BDBM105458 US8575203, II-74
BDBM105462 US8575203, II-78
BDBM105467 US8575203, II-83
BDBM105468 US8575203, II-84
BDBM105469 US8575203, II-85
BDBM105470 US8575203, II-86
BDBM105472 US8575203, II-88
BDBM105479 US8575203, II-95
BDBM105480 US8575203, II-96
BDBM105481 US8575203, II-97
BDBM105482 US8575203, II-98
BDBM105483 US8575203, II-99
BDBM105484 US8575203, II-100
BDBM105490 US8575203, II-106
BDBM186015 US9163010, Formula II
BDBM200933 US9533999, ii-2
BDBM200935 US9533999, ii-3
BDBM200938 US9533999, ii-6
BDBM200942 US9533999, ii-7
BDBM200946 US9533999, ii-8
BDBM200947 US9533999, ii-9
BDBM200952 US9533999, ii-12
BDBM200955 US9533999, ii-13
BDBM200963 US9533999, ii-14
BDBM200964 US9533999, ii-15
BDBM200965 US9533999, ii-16
BDBM200966 US9533999, ii-17
BDBM200967 US9533999, ii-18
BDBM200968 US9533999, ii-19
BDBM200969 US9533999, ii-20
BDBM200970 US9533999, ii-21
BDBM200971 US9533999, ii-22
BDBM200973 US9533999, ii-23
US8536166, II-5 BDBM102442
US8536166, II-6 BDBM102443
US8575203, II-101 BDBM105485
US8575203, II-102 BDBM105486
US8575203, II-103 BDBM105487
US8575203, II-104 BDBM105488
US8575203, II-16 BDBM105400
US8575203, II-17 BDBM105401
US8575203, II-19 BDBM105403
US8575203, II-26 BDBM105410
US8575203, II-28 BDBM105412
US8575203, II-29 BDBM105413
US8575203, II-36 BDBM105420
US8575203, II-38 BDBM105422
US8575203, II-46 BDBM105430
US8575203, II-47 BDBM105431
US8575203, II-48 BDBM105432
US8575203, II-5 BDBM105389
US8575203, II-57 BDBM105441
US8575203, II-58 BDBM105442
US8575203, II-59 BDBM105443
US8575203, II-6 BDBM105390
US8575203, II-60 BDBM105444
US8575203, II-68 BDBM105452
US8575203, II-7 BDBM105391
US8575203, II-71 BDBM105455
US8575203, II-79 BDBM105463
US8575203, II-8 BDBM105392
US8575203, II-80 BDBM105464
US8575203, II-81 BDBM105465
US8575203, II-82 BDBM105466
US8575203, II-90 BDBM105474
US8575203, II-91 BDBM105475
US9533999, ii-10 BDBM200948
US9533999, ii-5 BDBM200937